{"bill": {"#text": "\n\t", "official-title-amendment": {"#tail": "\n\t", "quote": {"#tail": ".", "#text": "A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize\n\t user fee programs relating to new animal drugs and generic new animal\n\t drugs."}, "#text": "Amend the title so as to read:\n\t "}, "form": {"current-chamber": {"#tail": "\n\t\t", "@display": "yes", "#text": "IN THE HOUSE OF\n\t\t  REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "@display": "yes", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1407"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and\n\t\t  Cosmetic Act to reauthorize user fee programs relating to new animal\n\t\t  drugs.", "@display": "yes", "pagebreak": {"#tail": "\n    "}}, "session": {"#tail": "\n\t\t", "@display": "yes", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "IB"}, "action": [{"action-date": {"#tail": "\n\t\t\t", "@date": "20130409", "#text": "April 9, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"@deleted-display-style": "strikethrough", "#tail": "\n      ", "@committee-id": "HIF00", "@added-display-style": "italic", "#text": "Committee on Energy and\n\t\t\t Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Shimkus", "@name-id": "S000364"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Gardner", "@name-id": "G000562"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Upton", "@name-id": "U000031"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Pitts", "@name-id": "P000373"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Waxman", "@name-id": "W000215"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Pallone", "@name-id": "P000034"}, {"#tail": ",\n\t\t\t ", "#text": "Mr. Burgess", "@name-id": "B001248"}, {"#tail": ", and\n\t\t\t ", "#text": "Mr. Guthrie", "@name-id": "G000558"}, {"#tail": ") introduced\n\t\t\t the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Kinzinger of Illinois", "@name-id": "K000378"}]}, "#text": "\n\t\t\t"}, {"action-date": {"#tail": "\n\t\t\t", "#text": "August 2, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t\t", "#text": "Reported with amendments, committed to the Committee of\n\t\t\t the Whole House on the State of the Union, and ordered to be\n\t\t\t printed"}, "#text": "\n\t\t\t", "action-instruction": [{"#tail": "\n\t\t\t", "#text": "Strike out all after the enacting clause and insert\n\t\t\t the part printed in italic"}, {"#tail": "\n\t\t", "#text": "For text of introduced bill, see copy of bill as\n\t\t\t introduced on April 9, 2013"}]}, {"#tail": "\n\t\t", "#text": "\n\t\t\t", "@display": "yes", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "@display": "yes", "pagebreak": {"#tail": "\n      "}}}], "associated-doc": {"#tail": "\n\t\t", "@display": "yes", "#text": "[Report No.\n\t\t  113\u2013188]", "@role": "report"}, "calendar": {"#tail": "\n\t\t", "@display": "yes", "#text": "Union Calendar No. 135"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Reported-in-House", "@bill-type": "olc", "endorsement": {"action-date": {"#tail": "\n\t\t", "#text": "August 2, 2013"}, "#tail": "\n", "@display": "yes", "action-desc": {"#tail": "\n\t", "#text": "Reported with amendments, committed to the Committee of the\n\t\t  Whole House on the State of the Union, and ordered to be printed"}, "#text": "\n\t\t"}, "@dms-id": "HF47D2515D4F744FD95CF09B98F7F9997", "@public-private": "public", "legis-body": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "title": [{"#tail": "\n    ", "section": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "101."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title;\n\t\t\t finding"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Animal Drug User Fee\n\t\t\t Amendments of 2013", "@value": "Animal Drug User Fee Amendments of 2013", "@proposed": "true"}, "#text": "\n              "}, "#text": "This title may be cited as the "}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short\n\t\t\t title"}, "#text": "\n          ", "@id": "H19F7F4F4EAE44A2FA9BBFDA7217BE46C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " finds that the fees authorized by\n\t\t\t the amendments made in this title will be dedicated toward expediting the\n\t\t\t animal drug development process and the review of new and supplemental animal\n\t\t\t drug applications and investigational animal drug submissions as set forth in\n\t\t\t the goals identified, for purposes of ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", in the letters from the ", "@entity-type": "act", "#text": "part 4 of subchapter C of chapter VII of\n\t\t\t the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, {"#tail": " to the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Chairman of the Committee on Energy and\n\t\t\t Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the\n\t\t\t Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on\n\t\t\t Health, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "\n            "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding"}, "#text": "\n          ", "@id": "HBB2F061037304EA2B8FBAB0048A4B6DC"}], "#text": "\n        ", "@id": "H534BB7E90262469980D59FD394E3EE1E"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 739 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:739"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201311", "@value": "usc/21/379j\u201311"}, "@parsable-cite": "usc/21/379j-11", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "102."}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For purposes of this part:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n            ", "#text": "739."}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ". Such term does not include either a new\n\t\t\t\tanimal drug application submitted under ", "@entity-type": "act", "#text": "section 512(b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:1"}, {"#tail": " or a supplemental\n\t\t\t\tanimal drug application.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}], "term": {"#tail": " means an application for approval of any new animal\n\t\t\t\tdrug submitted under ", "#text": "animal\n\t\t\t\tdrug application"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H72841A7FA7224BA981167715F095DA9A", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "supplemental animal drug application"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H5B36CF2EF2814ECDAD6DAD4BCCB10B77", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve a change in an animal drug application which has been\n\t\t\t\tapproved; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "a request to the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H67207ACF5BD54016A1C1224D8AB8FD75", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to approve a change to an application approved under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for which data with respect to safety or effectiveness are\n\t\t\t\trequired.", "@entity-type": "act", "#text": "section\n\t\t\t\t512(c)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:c/p:2"}], "#text": "a request to the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H38C1282566EB4FE1B3998FDFB4C87265", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means each specific strength or potency of a particular\n\t\t\t\tactive ingredient or ingredients in final dosage form marketed by a particular\n\t\t\t\tmanufacturer or distributor, which is uniquely identified by the labeler code\n\t\t\t\tand product code portions of the national drug code, and for which an animal\n\t\t\t\tdrug application or a supplemental animal drug application has been\n\t\t\t\tapproved.", "#text": "animal\n\t\t\t\tdrug product"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H3012AC2010064EA0A024CF0D7F9DDC91", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a foreign or domestic place of business which\n\t\t\t\tis at one general physical location consisting of one or more buildings all of\n\t\t\t\twhich are within 5 miles of each other, at which one or more animal drug\n\t\t\t\tproducts are manufactured in final dosage form.", "#text": "animal\n\t\t\t\tdrug establishment"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "H62FBC692AA3E45318DEE2F8B29776C75", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means\u2014", "#text": "investigational animal drug submission"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "#text": "\n              ", "@id": "H9B6AE47A48D44999AC2395BC04382949", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a new animal drug\n\t\t\t\tintended to be the subject of an animal drug application or a supplemental\n\t\t\t\tanimal drug application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a claim for\n\t\t\t\tan investigational exemption under "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H8772FDDCAA9C4C0C9C542C561C685DFD", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of an animal drug application or supplemental animal drug\n\t\t\t\tapplication in the event of their filing.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HB0AA407498D34A86A1F2B5CC4CDB65AC", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a person who has submitted an\n\t\t\t\tinvestigational animal drug submission that has not been terminated or\n\t\t\t\totherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": " means either an applicant named in an animal drug\n\t\t\t\tapplication that has not been withdrawn by the applicant and for which approval\n\t\t\t\thas not been withdrawn by the ", "#text": "animal\n\t\t\t\tdrug sponsor"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "@id": "HFC1D062A9E56483DA1A651F836F6773F", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means, with respect to an animal drug product, a finished\n\t\t\t\tdosage form which is approved for administration to an animal without\n\t\t\t\tsubstantial further manufacturing. Such term includes animal drug products\n\t\t\t\tintended for mixing in animal feeds.", "#text": "final\n\t\t\t\tdosage form"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "@id": "H922BD9429B85408A9E4CB31A4B3A5B44", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to the review of animal drug\n\t\t\t\tapplications, supplemental animal drug applications, and investigational animal\n\t\t\t\tdrug submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the following\n\t\t\t\tactivities of the ", "#text": "process\n\t\t\t\tfor the review of animal drug applications"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(8)"}, "#text": "\n              ", "@id": "HDD428FE76DF745EDA3AAF3545E4DF25E", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The activities necessary\n\t\t\t\tfor the review of animal drug applications, supplemental animal drug\n\t\t\t\tapplications, and investigational animal drug submissions."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HCFF2CFEC753A493BBA32379ACA6D503F", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The issuance of action\n\t\t\t\tletters which approve animal drug applications or supplemental animal drug\n\t\t\t\tapplications or which set forth in detail the specific deficiencies in animal\n\t\t\t\tdrug applications, supplemental animal drug applications, or investigational\n\t\t\t\tanimal drug submissions and, where appropriate, the actions necessary to place\n\t\t\t\tsuch applications, supplements, or submissions in condition for\n\t\t\t\tapproval."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H9C00610E60D64928A2CE2C0132A7B174", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\treview of pending animal drug applications, supplemental animal drug\n\t\t\t\tapplications, and investigational animal drug submissions.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}, "#text": "The inspection of animal\n\t\t\t\tdrug establishments and other facilities undertaken as part of the "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HEDC5C3C043024C799AD79C23A7F6E1FD", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Monitoring of research\n\t\t\t\tconducted in connection with the review of animal drug applications,\n\t\t\t\tsupplemental animal drug applications, and investigational animal drug\n\t\t\t\tsubmissions."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H93D6DFD06A73444186062A52BAF9AC79", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The development of\n\t\t\t\tregulations and policy related to the review of animal drug applications,\n\t\t\t\tsupplemental animal drug applications, and investigational animal drug\n\t\t\t\tsubmissions."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H3304768BB0C14C70AACE914839141F75", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Development of standards\n\t\t\t\tfor products subject to review."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H169EA086BF7C46C2951F8227A6CD74DF", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Meetings between the\n\t\t\t\tagency and the animal drug sponsor."}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "H4D70070D2599487A853C39210580C070", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Review of advertising and\n\t\t\t\tlabeling prior to approval of an animal drug application or supplemental animal\n\t\t\t\tdrug application, but not after such application has been approved."}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "HB411A53F48E84B7494C3488860E4A1CF", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the expenses in connection with the process for the\n\t\t\t\treview of animal drug applications for\u2014", "#text": "costs of\n\t\t\t\tresources allocated for the process for the review of animal drug\n\t\t\t\tapplications"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(9)"}, "#text": "\n              ", "@id": "H21AE991D4F6B4947863C447E891BDEF5", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", advisory committees consulted with respect to the review of\n\t\t\t\tspecific animal drug applications, supplemental animal drug applications, or\n\t\t\t\tinvestigational animal drug submissions, and costs related to such officers,\n\t\t\t\temployees, committees, and contractors, including costs for travel, education,\n\t\t\t\tand recruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, "#text": "officers and employees of\n\t\t\t\tthe Food and Drug Administration, contractors of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HC2416F08280D41B4A890F8B5720E3430", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "management of information\n\t\t\t\tand the acquisition, maintenance, and repair of computer resources;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HF2EC813134644BBD85DF4ABEC535FB2A", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "leasing, maintenance,\n\t\t\t\trenovation, and repair of facilities and acquisition, maintenance, and repair\n\t\t\t\tof fixtures, furniture, scientific equipment, and other necessary materials and\n\t\t\t\tsupplies; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HE196255E4A244651A82758FA9F071B78", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "collecting fees under\n\t\t\t\tsection 740 and accounting for resources allocated for the review of animal\n\t\t\t\tdrug applications, supplemental animal drug applications, and investigational\n\t\t\t\tanimal drug submissions."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "HD0F72CA5605D4DFB8E8973A3C27E8E3F", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with the base or comparator month being\n\t\t\t\tOctober 2002.", "@entity-type": "act", "#text": "section 735(8)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:8"}, "term": {"#tail": " applicable to a fiscal year refers to the\n\t\t\t\tformula set forth in ", "#text": "adjustment factor"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(10)"}, "@id": "H98F70436D2DC4635BD39D61FF7F6D0E1", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " includes an affiliate thereof.", "#text": "person"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(11)"}, "@id": "H66FB90D37BF84C45824969FD6319C920", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " refers to the definition set forth in ", "#text": "affiliate"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n              ", "#text": "(12)"}, "@id": "H4764C2B2F1FF473D900AAFB072773E5A", "#text": "\n              "}], "#text": "\n            ", "@id": "HCFE2BEB930894E4E874A785E5D8C85F1"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H08CD29B252824F06B9D1F6196E134B3C"}, "#text": "\n        ", "@id": "H5B3A475902894FABB16F5CC1DA256C8D"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201312", "@value": "usc/21/379j\u201312"}, "@parsable-cite": "usc/21/379j-12", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "103."}, "header": {"#tail": "\n        ", "#text": "Authority to assess\n\t\t\t and use animal drug fees"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to assess\n\t\t\t\tand use animal drug fees"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall assess\n\t\t\t\tand collect fees in accordance with this section as follows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning in fiscal year 2004, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for an animal drug application, except an\n\t\t\t\tanimal drug application described in ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}], "#text": "A\n\t\t\t\tfee established in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H735AD4C0861645C7ACD1A9FE3A0A3D45", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", in an amount that is equal to 50 percent of the amount of the\n\t\t\t\tfee under ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", for\u2014", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A/cl:i", "@proposed": "true"}], "#text": "A fee established in\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "a supplemental animal\n\t\t\t\tdrug application for which safety or effectiveness data are required;\n\t\t\t\tand"}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@id": "H273038FD718B46A3AE48F9FE12CD8EE3", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, "#text": "an animal drug\n\t\t\t\tapplication described in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@id": "H96B6B53C489048C39FA3F3C65EBD9192", "#text": "\n                      "}], "#text": "\n                    ", "@id": "H737F3F948E8C445EA40887FF388E39F0"}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person that submits, on or after September 1, 2003,\n\t\t\t\tan animal drug application or a supplemental animal drug application shall be\n\t\t\t\tsubject to a fee as follows:"}, "#text": "\n                  ", "@id": "H2850F9F710D8430B8B73CD7881B3BF75"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be due upon submission of the animal\n\t\t\t\tdrug application or supplemental animal drug application.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tfee required by "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment"}, "#text": "\n                  ", "@id": "H820161E5FAC549F4A0746E97DF9B54E8"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "If an animal drug\n\t\t\t\tapplication or a supplemental animal drug application was submitted by a person\n\t\t\t\tthat paid the fee for such application or supplement, was accepted for filing,\n\t\t\t\tand was not approved or was withdrawn (without a waiver or refund), the\n\t\t\t\tsubmission of an animal drug application or a supplemental animal drug\n\t\t\t\tapplication for the same product by the same person (or the person\u2019s licensee,\n\t\t\t\tassignee, or successor) shall not be subject to a fee under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Exception for\n\t\t\t\tpreviously filed application or supplement"}, "#text": "\n                  ", "@id": "H34EFF852139440039EA055E7DA4337D9"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any animal drug application\n\t\t\t\tor supplemental animal drug application which is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if\n\t\t\t\tapplication refused for filing"}, "#text": "\n                  ", "@id": "HCDD2A0B9DF4C4F2AB4ED5369C73ABB52"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or portion of the fee\n\t\t\t\tpaid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was performed on the\n\t\t\t\tapplication or supplement after the application or supplement was filed. The\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " shall have the sole discretion to refund the fee under this\n\t\t\t\tparagraph. A determination by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this\n\t\t\t\tparagraph shall not be reviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an animal drug application or a\n\t\t\t\tsupplemental animal drug application is withdrawn after the application or\n\t\t\t\tsupplement was filed, the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if\n\t\t\t\tapplication withdrawn"}, "#text": "\n                  ", "@id": "H79692D35C8B246BEB86312EBDD1CD718"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug application\n\t\t\t\tand supplement fee"}, "#text": "\n                ", "@id": "HAFC4DD877F7A465B80A89E1BE2D57F9C"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall pay for each such animal drug\n\t\t\t\tproduct the annual fee established in "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section\n\t\t\t\t510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as the\n\t\t\t\tapplicant in an animal drug application or supplemental animal drug application\n\t\t\t\tfor an animal drug product which has been submitted for listing under "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H6518D012E896490F805EE65D48402448", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application or\n\t\t\t\tsupplemental animal drug application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1,\n\t\t\t\t2003, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HF370DAF7DE8E4937A09E5209230C1C2B", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "H1598BC7B740D4A6190E5D68A9FBDE55B"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day\n\t\t\t\tafter the date of enactment of an appropriations Act providing for the\n\t\t\t\tcollection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H6E72D5FD83FF45D7A7F6BEAA84FD730C", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HD8CA794722FD490890EB9707314CC307", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee due\n\t\t\t\tdate"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is\n\t\t\t\tsubmitted for relisting under ", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the animal drug product has been\n\t\t\t\twithdrawn from listing and relisted. After such fee is paid for that fiscal\n\t\t\t\tyear, such fee shall be due each subsequent fiscal year that the product\n\t\t\t\tremains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which the\n\t\t\t\tanimal drug product is first submitted for listing under "}, "#text": "\n                  ", "@id": "H853BED0DBAE64E479AC75EE4361292FB"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such\n\t\t\t\tfee shall be paid only once for each animal drug product for a fiscal year in\n\t\t\t\twhich the fee is payable."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "HD4993A31BAEA49C7870972A2BEF8A741"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug product\n\t\t\t\tfee"}, "#text": "\n                ", "@id": "HBB47C4FFBC054D489B109123754F5FF3"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for each animal drug establishment listed\n\t\t\t\tin its approved animal drug application as an establishment that manufactures\n\t\t\t\tthe animal drug product named in the application.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual establishment\n\t\t\t\tfee as established in "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who owns or operates,\n\t\t\t\tdirectly or through an affiliate, an animal drug establishment;"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H9A20CCED3C6B4A6F8FBF53CD3410C996", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "section\n\t\t\t\t510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, "#text": "who is named as the\n\t\t\t\tapplicant in an animal drug application or supplemental animal drug application\n\t\t\t\tfor an animal drug product which has been submitted for listing under "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HA9854157557A43D8B0B03986F778B56F", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application or\n\t\t\t\tsupplemental animal drug application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1,\n\t\t\t\t2003, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "HEDEE1677E51147C6B695ECFFFD3F974F", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "H9C7A98F390794FD1B24B3912C1A8CAA7"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day\n\t\t\t\tafter the date of enactment of an appropriations Act providing for the\n\t\t\t\tcollection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H1DF9B179D898447E934A27C4D6CDCA33", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H7F9C0189F8E2492F96107D98B721F5AA", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee due\n\t\t\t\tdate"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " unless the animal drug establishment listed\n\t\t\t\tin the application does not engage in the manufacture of the animal drug\n\t\t\t\tproduct during the fiscal year. The fee under this paragraph for a fiscal year\n\t\t\t\tshall be due upon the later of\u2014", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "The annual establishment fee shall be assessed in each\n\t\t\t\tfiscal year in which the animal drug product named in the application is\n\t\t\t\tassessed a fee under "}, "#text": "\n                  ", "@id": "HEED38BA79A5043AFBCBE58C755B068E2"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3/sp:C/cl:ii", "@proposed": "true"}, "#text": "An establishment shall be assessed only one fee per\n\t\t\t\tfiscal year under this section, subject to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                    ", "@id": "HD67E32A99E4C42DEADE5C2FFD14E3866"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ",\n\t\t\t\tsuch establishment shall be assessed both the animal drug establishment fee and\n\t\t\t\tthe prescription drug establishment fee, as set forth in ", "@entity-type": "act", "#text": "section 735(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:3"}, {"#tail": ",\n\t\t\t\twithin a single fiscal year.", "@entity-type": "act", "#text": "section 736(a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:736/ss:a/p:2"}], "#text": "If a single establishment manufactures both animal\n\t\t\t\tdrug products and prescription drug products, as defined in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain\n\t\t\t\tmanufacturers"}, "#text": "\n                    ", "@id": "H9E9D0C33EE7F4783A12E8BB1E16E692B"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Limitation"}, "#text": "\n                  ", "@id": "H0FD52D0D896A4C308C99D125A53604A8"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug\n\t\t\t\testablishment fee"}, "#text": "\n                ", "@id": "H53572BC249F947B9B492210B5B001658"}, {"#tail": "\n            ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual sponsor fee\n\t\t\t\tas established under "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the definition\n\t\t\t\tof an animal drug sponsor within a fiscal year; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H3ACBF72C32644CF394D3A67859B31208", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an animal drug application, a\n\t\t\t\tsupplemental animal drug application, or an investigational animal drug\n\t\t\t\tsubmission,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1,\n\t\t\t\t2003, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H93EA6A384B1F435CBAAE9C56A4254218", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "H84D8FC635BEC4EF2A4C6B2F790C3E4C2"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day\n\t\t\t\tafter the date of enactment of an appropriations Act providing for the\n\t\t\t\tcollection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H6682DC03F7EC47DF813E90693F587C45", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HDD2D786087D241B5B38410C17DFF4EA4", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee due\n\t\t\t\tdate"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fee under this paragraph for a fiscal year shall be due\n\t\t\t\tupon the later of\u2014"}, "#text": "\n                  ", "@id": "H08F404279F9A4EFDA87778F7E6102562"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Each\n\t\t\t\tanimal drug sponsor shall pay only one such fee each fiscal year."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "H89FDF3A3BC14492F84D7935DFA33B095"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Animal drug sponsor\n\t\t\t\tfee"}, "#text": "\n                ", "@id": "H96BEDC6263A242F6A26F162823610EB0"}], "#text": "\n              ", "@id": "HA500060558E449029404DCDEDAA6F590"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee revenue\n\t\t\t\tamounts"}, "paragraph": [{"#tail": "\n              ", "@id": "H782EC3137BF84CFEAFA14576F18EA30E", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f", "@proposed": "true"}, {"#tail": "\u2014", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g", "@proposed": "true"}], "#text": "Subject to "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be established to generate a total\n\t\t\t\trevenue amount of $23,600,000; and", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for fiscal year 2014, the\n\t\t\t\tfees required under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H9D6139286D7D4A2FB5BA1B9308963BF8", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be established\n\t\t\t\tto generate a total revenue amount of $21,600,000.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, "#text": "for each of fiscal years\n\t\t\t\t2015 through 2018, the fees required under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HB7141A84282D44B8BB0CA5AE97C7618A", "#text": "\n                  "}]}, {"#tail": "\n            ", "@id": "H5A250AFDF60E4E0894A80D655A7D3ABC", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Types of\n\t\t\t\tfees"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b/p:1", "@proposed": "true"}, "#text": "Of the total revenue amount determined for a fiscal year\n\t\t\t\tunder "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug applications\n\t\t\t\tand supplements);", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:1", "@proposed": "true"}, "#text": "20 percent shall be\n\t\t\t\tderived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H43EE68EE8219495B8BA2BB36EC70E11B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tproducts);", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:2", "@proposed": "true"}, "#text": "27 percent shall be\n\t\t\t\tderived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H2EEA54B8435E4ABD915A162B006359C4", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\testablishments); and", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:3", "@proposed": "true"}, "#text": "26 percent shall be\n\t\t\t\tderived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HB302CBF46F1145648082BAAC189FD9EB", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (relating to animal drug\n\t\t\t\tsponsors).", "@entity-type": "act", "#text": "subsection (a)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a/p:4", "@proposed": "true"}, "#text": "27 percent shall be\n\t\t\t\tderived from fees under "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H86D0B49326594462BB4D8FCDE95B5E66", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "HE6E8954D05A2485F8082D787B0B6984E"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee setting;\n\t\t\t\tadjustments"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2003, for that fiscal year,\n\t\t\t\tanimal drug application fees, supplemental animal drug application fees, animal\n\t\t\t\tdrug sponsor fees, animal drug establishment fees, and animal drug product fees\n\t\t\t\tbased on the revenue amounts established under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the\n\t\t\t\tadjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee\n\t\t\t\tsetting"}, "#text": "\n                ", "@id": "H582AF305DD214DDA87329EA5BD6E21F0"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "The\n\t\t\t\tadjustment made each fiscal year under this paragraph shall be added on a\n\t\t\t\tcompounded basis to the sum of all adjustments made each fiscal year after\n\t\t\t\tfiscal year 2014 under this paragraph."}, "#tail": "\n              ", "@id": "H342468B164FB4AA987729089013493EA", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Inflation\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be adjusted by the\n\t\t\t\tSecretary by notice, published in the Federal Register, for a fiscal year, by\n\t\t\t\tan amount equal to the sum of\u2014", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, "#text": "For fiscal year 2015 and subsequent fiscal years, the\n\t\t\t\trevenue amounts established in "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "one;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HC8D1B5EAAC7546CD8EA25976FDA23230", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", of all personnel compensation and benefits paid with\n\t\t\t\trespect to such positions for the first 3 of the preceding 4 fiscal years for\n\t\t\t\twhich data are available, multiplied by the average proportion of personnel\n\t\t\t\tcompensation and benefits costs to total ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}, {"#tail": " costs for\n\t\t\t\tthe first 3 years of the preceding 4 fiscal years for which data are available;\n\t\t\t\tand", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "the average annual\n\t\t\t\tpercent change in the cost, per full-time equivalent position of the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HF7D77472C251432EBB462EF9831AFD9C", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " costs for the first 3 years of the preceding 4 fiscal years for\n\t\t\t\twhich data are available.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t\tAdministration", "@entity-id": "7524"}, "#text": "the average annual\n\t\t\t\tpercent change that occurred in the Consumer Price Index for urban consumers\n\t\t\t\t(Washington-Baltimore, DC-MD-VA-WV; not seasonally adjusted; all items less\n\t\t\t\tfood and energy; annual index) for the first 3 years of the preceding 4 years\n\t\t\t\tfor which data are available multiplied by the average proportion of all costs\n\t\t\t\tother than personnel compensation and benefits costs to total "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H8B14B37F900646528DBB5F97CD648550", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "HFF4F6E62121C4CD496EDB2116B07B92A", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Workload\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " are adjusted for\n\t\t\t\tinflation in accordance with ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ", the revenue amounts shall be\n\t\t\t\tfurther adjusted for such fiscal year to reflect changes in the workload of the\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}, {"#tail": " for the process for the review of animal drug applications. With\n\t\t\t\trespect to such adjustment\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For fiscal year 2015 and subsequent fiscal years,\n\t\t\t\tafter the revenue amounts established in "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change in the\n\t\t\t\ttotal number of animal drug applications, supplemental animal drug applications\n\t\t\t\tfor which data with respect to safety or effectiveness are required,\n\t\t\t\tmanufacturing supplemental animal drug applications, investigational animal\n\t\t\t\tdrug study submissions, and investigational animal drug protocol submissions\n\t\t\t\tsubmitted to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "such adjustment shall be\n\t\t\t\tdetermined by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H260E2FB9105C42A78F3D8771E766D284", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\n\t\t\t\tpublish in the Federal Register the fees resulting from such adjustment and the\n\t\t\t\tsupporting methodologies; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H483CF1E01BC94B68AA324C999B1FD47C", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as\n\t\t\t\tadjusted for inflation under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c/p:2", "@proposed": "true"}], "#text": "under no circumstances\n\t\t\t\tshall such adjustment result in fee revenues for a fiscal year that are less\n\t\t\t\tthan the fee revenues for that fiscal year established in "}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H14AB7745E5E34BB9A2D657A1F371F68B", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in addition\n\t\t\t\tto other adjustments under this subsection, further increase the fees under\n\t\t\t\tthis section, if such an adjustment is necessary to provide for up to 3 months\n\t\t\t\tof operating reserves of carryover user fees for the process for the review of\n\t\t\t\tanimal drug applications for the first 3 months of fiscal year 2019. If the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances for the process for the\n\t\t\t\treview of animal drug applications in excess of 3 months of such operating\n\t\t\t\treserves, then this adjustment will not be made. If this adjustment is\n\t\t\t\tnecessary, then the rationale for the amount of the increase shall be contained\n\t\t\t\tin the annual notice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final year\n\t\t\t\tadjustment"}, "#text": "\n                ", "@id": "HE56A76CC17094266BC4EB44D4CD931FB"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\ttotal amount of fees charged, as adjusted under this subsection, for a fiscal\n\t\t\t\tyear may not exceed the total costs for such fiscal year for the resources\n\t\t\t\tallocated for the process for the review of animal drug applications."}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Limit"}, "#text": "\n                ", "@id": "HEE7B57306E2845E4B70762202DE653F5"}], "#text": "\n              ", "@id": "H35A84DD218D347A496797A4F650EAC45"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Fee waiver or\n\t\t\t\treduction"}, "paragraph": [{"#tail": "\n              ", "@id": "H13739E0E138F46AB8753B7C68DF227FA", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction of\n\t\t\t\tone or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " finds\n\t\t\t\tthat\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the assessment of the fee\n\t\t\t\twould present a significant barrier to innovation because of limited resources\n\t\t\t\tavailable to such person or other circumstances;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HB67B7B0052F54B9EA93AFF6EA4AE1096", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in conducting the process for the review of animal drug\n\t\t\t\tapplications for such person;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the fees to be paid by\n\t\t\t\tsuch person will exceed the anticipated present and future costs incurred by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H1CDDF0DAD4A04AB18EA2D30A1BFBF8D9", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the animal drug\n\t\t\t\tapplication or supplemental animal drug application is intended solely to\n\t\t\t\tprovide for use of the animal drug in\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a Type B medicated feed\n\t\t\t\t(as defined in ", "external-xref": {"#tail": " of title 21, Code of Federal Regulations (or\n\t\t\t\tany successor regulation)) intended for use in the manufacture of Type C\n\t\t\t\tfree-choice medicated feeds; or", "@parsable-cite": "cfr/21/558.3", "#text": "section 558.3(b)(3)", "@legal-doc": "regulation"}}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H936444C56BC349A494A964947BCBE18B", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a Type C free-choice\n\t\t\t\tmedicated feed (as defined in ", "external-xref": {"#tail": " of title 21, Code of Federal\n\t\t\t\tRegulations (or any successor regulation));", "@parsable-cite": "usc/21/558", "#text": "section 558.3(b)(4)", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H686D711B269141DC84A1A4620F678751", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H54C8C230684644D1A8A0F2F3846D70AE"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the animal drug\n\t\t\t\tapplication or supplemental animal drug application is intended solely to\n\t\t\t\tprovide for a minor use or minor species indication; or"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H511E31AD18EE48F3A2D488D66734E415", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tfor review.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the sponsor involved is a\n\t\t\t\tsmall business submitting its first animal drug application to the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H35670E833EDB461494EAE4A93252ED4A", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (1)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:B", "@proposed": "true"}, {"#tail": "\n\t\t\t\tmay use standard costs.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In making the finding in "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Use of standard\n\t\t\t\tcosts"}, "#text": "\n                ", "@id": "H92AD4E2F7C954D91BAFCABFA1DDE908E"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the term ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, "term": {"#tail": " means an entity that has\n\t\t\t\tfewer than 500 employees, including employees of affiliates.", "#text": "small business"}, "#text": "In\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Definition"}, "#text": "\n                  ", "@id": "H4EE3339060AD4901B1EDF7531D5E8574"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall waive under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the\n\t\t\t\tapplication fee for the first animal drug application that a small business or\n\t\t\t\tits affiliate submits to the ", "@entity-type": "act", "#text": "paragraph (1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " for review. After a small business or\n\t\t\t\tits affiliate is granted such a waiver, the small business or its affiliate\n\t\t\t\tshall pay application fees for all subsequent animal drug applications and\n\t\t\t\tsupplemental animal drug applications for which safety or effectiveness data\n\t\t\t\tare required in the same manner as an entity that does not qualify as a small\n\t\t\t\tbusiness.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Waiver of application\n\t\t\t\tfee"}, "#text": "\n                  ", "@id": "HA5BB2BAA0F8043199DDAD70A7888309C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require any person who applies for a waiver under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to certify their qualification for the waiver. The ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(1)(E)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": " shall\n\t\t\t\tperiodically publish in the Federal Register a list of persons making such\n\t\t\t\tcertifications.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Certification"}, "#text": "\n                  ", "@id": "HB89DAA6396CA4E0E8B5AABFB95304C8A"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Rules for small\n\t\t\t\tbusinesses"}, "#text": "\n                ", "@id": "HE5FCF679738C462CA1CF56F7635BEB9B"}], "#text": "\n              ", "@id": "HA6BD17F5C24F4037A80481D67797C5EE"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered incomplete and shall not be accepted for filing by the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person have been paid. An investigational\n\t\t\t\tanimal drug submission under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " that is submitted by a person\n\t\t\t\tsubject to fees under ", "@entity-type": "act", "#text": "section 739(5)(B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:739/p:5/sp:B"}, {"#tail": " shall be considered incomplete and shall\n\t\t\t\tnot be accepted for review by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " until all fees owed by such person\n\t\t\t\thave been paid. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may discontinue review of any animal drug\n\t\t\t\tapplication, supplemental animal drug application, or investigational animal\n\t\t\t\tdrug submission from a person if such person has not submitted for payment all\n\t\t\t\tfees owed under this section by 30 days after the date upon which they are\n\t\t\t\tdue.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An animal drug application or supplemental\n\t\t\t\tanimal drug application submitted by a person subject to fees under "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of failure To\n\t\t\t\tpay fees"}, "#text": "\n              ", "@id": "H64213ABB1C9044E782562FA1727EA78A"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2003 unless appropriations for salaries and expenses of the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the Food and Drug\n\t\t\t\tAdministration for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "federal-body", "#text": "Food\n\t\t\t\tand Drug Administration", "@entity-id": "7524"}], "#text": "Fees\n\t\t\t\tmay not be assessed under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "#text": "\n                ", "@id": "HEED8BE69DC9249EA89062123D765BE7B"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a\n\t\t\t\tfiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " and if at a later date in such fiscal year\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such\n\t\t\t\tfees, without any modification in the rate, for animal drug applications,\n\t\t\t\tsupplemental animal drug applications, investigational animal drug submissions,\n\t\t\t\tanimal drug sponsors, animal drug establishments, and animal drug products at\n\t\t\t\tany time in such fiscal year notwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\trelating to the date fees are to be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority"}, "#text": "\n                ", "@id": "H2C80F52B58874658B6394B9C395E54D5"}], "#text": "\n              ", "@id": "HC0BC07093B0B4034B5DB9DC2D4EDE704"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of animal drug applications.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "H080F149F717E4031BA027C426B0717B9"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be collected and available in each fiscal year in an amount not to\n\t\t\t\texceed the amount specified in appropriation Acts, or otherwise made available\n\t\t\t\tfor obligation for such fiscal year; and", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H4062DD30087540068C483091E1FB031D", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be engaged in such process) over such costs,\n\t\t\t\texcluding costs paid from fees collected under this section, for fiscal year\n\t\t\t\t2003 multiplied by the adjustment factor.", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t\tHealth and Human Services", "@entity-id": "7500"}, "#text": "shall be available to\n\t\t\t\tdefray increases in the costs of the resources allocated for the process for\n\t\t\t\tthe review of animal drug applications (including increases in such costs for\n\t\t\t\tan additional number of full-time equivalent positions in the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HD79E54220D0E438C89EBEC4AEEC735E5", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014"}, "#text": "\n                  ", "@id": "H9540E04251FB4AB5B552EE386D26BEC3"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than 3\n\t\t\t\tpercent below the level specified in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H5AB30CE0C6E54EFF8AC54963A0881D38", "#text": "\n                    "}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the\n\t\t\t\tfiscal year following the subsequent fiscal year are decreased by the amount in\n\t\t\t\texcess of 3 percent by which such costs fell below the level specified in\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "H6384908455BF4208A421F5B5CB8694FE", "@commented": "no"}, {"@committee-id": "HIF00", "@changed": "added", "@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more\n\t\t\t\tthan 5 percent below the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                      ", "@id": "H9DAA042F88B9494D915DAF7E5694CAC5"}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HC880507E345D4C32A15AA4A3A3E9252E", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Compliance"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of animal drug applications\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "#text": "\n                  ", "@id": "H6696935B160646F5B5BC299C3B2FB755"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior year\n\t\t\t\tappropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this section for a\n\t\t\t\tfiscal year, prior to the due date for such fees, may be accepted by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for early\n\t\t\t\tpayments"}, "#text": "\n                  ", "@id": "HE9EEDBE528984E3FA254DF8C24EF2D58"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and\n\t\t\t\tappropriation acts"}, "#text": "\n                ", "@id": "HA7FB552EED714EBE8A1337145757689E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "\n                  ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for the\n\t\t\t\tfiscal year, as adjusted or otherwise affected under ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:b", "@proposed": "true"}, {"#tail": " and\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:c", "@proposed": "true"}, {"#tail": "\n                    ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4", "@proposed": "true"}], "@amount": "indefinite", "#text": "an amount\n\t\t\t\tequal to the total revenue amount determined under ", "@year": "2014, 2015, 2016, 2017, 2018"}, "@entity-type": "auth-auth-approp", "#text": "For each of the fiscal years 2014 through 2018,\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}property": {"#tail": " ", "#text": "there is authorized to be appropriated for fees under this section", "@name": "purpose"}}}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorization of\n\t\t\t\tappropriations"}, "#text": "\n                ", "@id": "H40302893F1FC44E1BBF56B272466ECAF"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "),\n\t\t\t\texceeds the cumulative amount appropriated pursuant to ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:B", "@proposed": "true"}, {"#tail": " for the\n\t\t\t\tfiscal years 2014 through 2017, the excess amount shall be credited to the\n\t\t\t\tappropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from the amount of fees that would\n\t\t\t\totherwise be authorized to be collected under this section pursuant to\n\t\t\t\tappropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:1", "@proposed": "true"}], "#text": "If the sum of the cumulative amount of fees\n\t\t\t\tcollected under this section for fiscal years 2014 through 2016 and the amount\n\t\t\t\tof fees estimated to be collected under this section for fiscal year 2017\n\t\t\t\t(including any increased fee collections attributable to "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Offset of\n\t\t\t\tovercollections"}, "#text": "\n                  ", "@id": "HCFDB581EDCDC41988A36527B1FD2804A"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2016, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2014 falls below the amount of fees authorized for fiscal year 2014\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2016"}, "#text": "\n                    ", "@id": "H566512AB0CEB46FD8940237BC14F63C1"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}, "#text": "For fiscal year 2017, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section shall be increased by the amount,\n\t\t\t\tif any, by which the amount collected under this section and appropriated for\n\t\t\t\tfiscal year 2015 falls below the amount of fees authorized for fiscal year 2015\n\t\t\t\tunder "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2017"}, "#text": "\n                    ", "@id": "H8E773F6313A642C3A0E265C6373BB790"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), shall be increased by the cumulative\n\t\t\t\tamount, if any, by which the amount collected under this section and\n\t\t\t\tappropriated for fiscal years 2016 and 2017 (including estimated collections\n\t\t\t\tfor fiscal year 2017) falls below the cumulative amount of fees authorized\n\t\t\t\tunder ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:4/sp:A", "@proposed": "true"}, {"#tail": " for fiscal years 2016 and 2017.", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:g/p:3", "@proposed": "true"}], "#text": "For fiscal year 2018, the amount of fees otherwise\n\t\t\t\tauthorized to be collected under this section (including any reduction in the\n\t\t\t\tauthorized amount under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "header": {"#tail": "\n                    ", "#text": "Fiscal year\n\t\t\t\t2018"}, "#text": "\n                    ", "@id": "HD5A9AFA1B5B94D9688DF83EACDBC77C9"}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Recovery of collection\n\t\t\t\tshortfalls"}, "#text": "\n                  ", "@id": "HBAD65866F630456EBD19B6C32E2085F4"}], "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Offset of\n\t\t\t\tovercollections; recovery of collection shortfalls"}, "#text": "\n                ", "@id": "H2820D0DF76774109BAE7466ACCF40E8C"}], "#text": "\n              ", "@id": "H9ABB455980F84803861E6BBF43DA5913"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive payment of\n\t\t\t\ta fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it is due, such fee\n\t\t\t\tshall be treated as a claim of the United States Government subject to\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of unpaid\n\t\t\t\tfees"}, "#text": "\n              ", "@id": "H4EEFF5DF674648A484B299BFF5F9377D"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund of any fee\n\t\t\t\tcollected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit to the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not later\n\t\t\t\tthan 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for consideration for\n\t\t\t\ta waiver or reduction under "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written requests for\n\t\t\t\twaivers, reductions, and refunds"}, "#text": "\n              ", "@id": "H97FFE12AD7C74BFF95C773B4E10E5AFF"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tanimal drug applications, be reduced to offset the number of officers,\n\t\t\t\temployees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the "}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction"}, "#text": "\n              ", "@id": "HA69EE2B79432464F94DAF7118FAEE569"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Abbreviated new animal\n\t\t\t\tdrug applications"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "to the extent\n\t\t\t\tpracticable, segregate the review of abbreviated new animal drug applications\n\t\t\t\tfrom the process for the review of animal drug applications; and"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "HCDCCD3965F6F4BEF84E7452470F2808E", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "adopt other\n\t\t\t\tadministrative procedures to ensure that review times of abbreviated new animal\n\t\t\t\tdrug applications do not increase from their current level due to activities\n\t\t\t\tunder the user fee\n\t\t\t\tprogram."}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "HBFD8240E38534E7FB1A4CACB35FE2159", "#text": "\n                "}], "#text": "\n              ", "@id": "H198403CABCFE4992B2DAF581BD78C358"}], "#text": "\n            ", "@id": "H31437D02B50A4F4E8B117D3885CFCAE0"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H79BED06A57FF40CB8CB754BCB8B18510"}, "#text": "\n        ", "@id": "HDFCACF2D7F6048B094CEE81934FFC369"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740A of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201313", "@value": "usc/21/379j\u201313"}, "@parsable-cite": "usc/21/379j-13", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "104."}, "header": {"#tail": "\n        ", "#text": "Reauthorization;\n\t\t\t reporting requirements"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "740A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization;\n\t\t\t\treporting requirements"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and\n\t\t\t\tsubmit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tand the ", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " a\n\t\t\t\treport concerning the progress of the ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " in achieving\n\t\t\t\tthe goals identified in the letters described in ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " toward expediting the animal drug development\n\t\t\t\tprocess and the review of the new and supplemental animal drug applications and\n\t\t\t\tinvestigational animal drug submissions during such fiscal year, the future\n\t\t\t\tplans of the ", "@entity-type": "act", "#text": "section 101(b) of the Animal\n\t\t\t\tDrug User Fee Amendments of 2013", "@value": "Animal Drug User Fee Amendments of 2013/s:101/ss:b", "@proposed": "true"}, {"#tail": " for meeting the goals, the review\n\t\t\t\ttimes for abbreviated new animal drug applications, and the administrative\n\t\t\t\tprocedures adopted by the ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " to ensure that review\n\t\t\t\ttimes for abbreviated new animal drug applications are not increased from their\n\t\t\t\tcurrent level due to activities under the user fee program.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal\n\t\t\t\tyear 2014, not later than 120 days after the end of each fiscal year during\n\t\t\t\twhich fees are collected under this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance\n\t\t\t\treport"}, "#text": "\n              ", "@id": "HCC616D0AEA22415DA5A02F578111E26B"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and\n\t\t\t\tsubmit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\tand the ", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " a\n\t\t\t\treport on the implementation of the authority for such fees during such fiscal\n\t\t\t\tyear and the use, by the ", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": ", of the fees collected\n\t\t\t\tduring such fiscal year for which the report is made.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal\n\t\t\t\tyear 2014, not later than 120 days after the end of each fiscal year during\n\t\t\t\twhich fees are collected under this part, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal\n\t\t\t\treport"}, "#text": "\n              ", "@id": "H1316FAAB2BF34C6B8579A29F9CF6D5B2"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports required under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet Web site of the\n\t\t\t\tFood and Drug Administration.", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n              ", "@id": "H7A6A0C64BC2F4022828F268D5D2B5FE0"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization"}, "paragraph": [{"#tail": "\n              ", "@id": "HEC3CB33BD01D415EA4D6444E580FB8E2", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the\n\t\t\t\tgoals, and plans for meeting the goals, for the process for the review of\n\t\t\t\tanimal drug applications for the first 5 fiscal years after fiscal year 2018,\n\t\t\t\tand for the reauthorization of this part for such fiscal years, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": "\n\t\t\t\tshall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Energy\n\t\t\t\tand Commerce of the House of Representatives", "@entity-id": "HIF00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                  ", "@id": "HD5AC860A85994475A4D0D998629F8290", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                  ", "@id": "HD044F906A2734BA3B8E3F2F8B84C2FD3", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and academic\n\t\t\t\texperts;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H490AD63C0C04453B98F943685AFDB45B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary\n\t\t\t\tprofessionals;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "HAE438C0F818149D0B636100855435B5E", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives of\n\t\t\t\tpatient and consumer advocacy groups; and"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H0316E15A48B54425B6A12D8A9A92F881", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated\n\t\t\t\tindustry."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "H45D1615C309B4E9D87FC20FF90039171", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "H8EA67A72F85547B7A28E4800C741EB30", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public\n\t\t\t\tinput"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the regulated industry\n\t\t\t\ton the reauthorization of this part, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice in the\n\t\t\t\tFederal Register requesting public input on the reauthorization;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HB7C28E8CC4934829980F2FF88C64C135", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:a", "@proposed": "true"}, "#text": "hold a public meeting at\n\t\t\t\twhich the public may present its views on the reauthorization, including\n\t\t\t\tspecific suggestions for changes to the goals referred to in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H6DEE873A3450455384396974C68B7637", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period of 30\n\t\t\t\tdays after the public meeting to obtain written comments from the public\n\t\t\t\tsuggesting changes to this part; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H317F931FBE4846738DAA1F0C37A69487", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish the comments on\n\t\t\t\tthe Food and Drug Administration\u2019s Internet Web site."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "HDFF75E88BD574D0DA23B93300FD944A2", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall hold discussions\n\t\t\t\twith representatives of veterinary, patient, and consumer advocacy groups to\n\t\t\t\tcontinue discussions of their views on the reauthorization and their\n\t\t\t\tsuggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4 months during\n\t\t\t\tnegotiations with the regulated industry, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic\n\t\t\t\tconsultation"}, "#text": "\n                ", "@id": "HF2B386603B3649D8BA6F6A0242FBBB4F"}, {"#tail": "\n              ", "@id": "H1184E001052C4FFFB12AC8E027FA5585", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review of\n\t\t\t\trecommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After negotiations with the regulated industry,\n\t\t\t\tthe "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the congressional committees\n\t\t\t\tspecified in such paragraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1", "@proposed": "true"}, "#text": "present the\n\t\t\t\trecommendations developed under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H071B911562564FB7B3136B1CBC580F59", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such\n\t\t\t\trecommendations in the Federal Register;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HAA9E4838F34E445A916B716C1EBA2815", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a period of\n\t\t\t\t30 days for the public to provide written comments on such\n\t\t\t\trecommendations;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H11682AABE41F4726BBBDC084020B21CD", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at which\n\t\t\t\tthe public may present its views on such recommendations; and"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "HB1696A268D534001B1C0C55FB95B426E", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after consideration of\n\t\t\t\tsuch public views and comments, revise such recommendations as\n\t\t\t\tnecessary."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H05751329D470478CBB48D7DCD205C761", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall transmit to Congress the revised recommendations under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", a\n\t\t\t\tsummary of the views and comments received under such paragraph, and any\n\t\t\t\tchanges made to the recommendations in response to such views and\n\t\t\t\tcomments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:4", "@proposed": "true"}], "#text": "Not later than January 15, 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations"}, "#text": "\n                ", "@id": "HC0408B947CB541A3BD2073711C0BC3E5"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to\n\t\t\t\tCongress, the ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:1..5", "@proposed": "true"}, {"#tail": " shall make publicly available, on the Internet Web site\n\t\t\t\tof the Food and Drug Administration, minutes of", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the regulated industry.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Before\n\t\t\t\tpresenting the recommendations developed under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\u201d all negotiation meetings conducted under this subsection between the\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ")", "@entity-type": "statute-at-large", "#text": "122 Stat.\n\t\t\t\t3509", "@value": "statute-at-large/122/3509"}, "@entity-type": "law-citation", "#text": "\n                      ", "external-xref": {"#tail": " (", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, "@parsable-cite": "pl/110/316", "#text": "\n                        ", "@legal-doc": "public-law"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n                  ", "@id": "H99B8DA59C9974935A057E89FDE2024EF"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive\n\t\t\t\tproposal made by any party to the negotiations as well as significant\n\t\t\t\tcontroversies or differences of opinion during the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tminutes described under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content"}, "#text": "\n                  ", "@id": "H1ED37DEB8D1B48C3A0FD387F6E8F83BD"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of negotiation\n\t\t\t\tmeetings"}, "#text": "\n                ", "@id": "HC798FA718A804B398943E7219DF9F0A4"}], "#text": "\n              ", "@id": "H7A99EA3115AA416BBE00CD62928F6350"}], "#text": "\n            ", "@id": "H42CF024851684B91B70104BD8AB19AB3"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HC478B5E5BEDD4B4B96FA939FEE25AF2B"}, "#text": "\n        ", "@id": "H4B0D57F4F492484AB0026477B82E2463"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for filing with respect to assessing and collecting any fee\n\t\t\t required by such part for a fiscal year prior to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}, "#text": "Notwithstanding the\n\t\t\t amendments made by this title, ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as in effect\n\t\t\t on the day before the date of the enactment of this title, shall continue to be\n\t\t\t in effect with respect to animal drug applications and supplemental animal drug\n\t\t\t applications (as defined in such part as of such day) that on or after October\n\t\t\t 1, 2008, but before October 1, 2013, were accepted by the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "part 4 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201311 et seq.", "@value": "usc/21/379j\u201311/etseq"}, "@parsable-cite": "usc/21/379j-11", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "105."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause"}, "#text": "\n        ", "@id": "H0990EE7E1BA84E86963A121F3E3E804F"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all animal drug applications and supplemental\n\t\t\t animal drug applications received on or after October 1, 2013, regardless of\n\t\t\t the date of the enactment of this title.", "@entity-type": "act", "#text": "part 4 of subchapter C\n\t\t\t of chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:4"}, "#text": "The amendments made by\n\t\t\t this title shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this title, whichever is later, except that fees under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "106."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "H68DC208E871C4EE2BE4E11FC32B5AA99"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "107."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset dates"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 740 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201312", "@value": "usc/21/379j\u201312"}, "@parsable-cite": "usc/21/379j-12", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization"}, "#text": "\n          ", "@id": "H31DD3BF3696B4D59AB9015877206C3C0"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 740A of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:740A"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201313", "@value": "usc/21/379j\u201313"}, "@parsable-cite": "usc/21/379j-13", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting\n\t\t\t requirements"}, "#text": "\n          ", "@id": "H149C580C57D0435FA5B39B2C35095F0B"}, {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset\n\t\t\t provision"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 108 of the Animal Drug User Fee Amendments of\n\t\t\t 2008", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, "@parsable-cite": "pl/110/316", "#text": "\n                  ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t general"}, "#text": "\n            ", "@id": "H256BB840A1E149BB9554E8C34B88AC15"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", by striking\n\t\t\t the item relating to ", "@entity-type": "act", "#text": "section 1", "@value": "Animal Drug User Fee Amendments of 2008/s:1"}, {"#tail": ".", "@entity-type": "act", "#text": "section 108", "@value": "Animal Drug User Fee Amendments of 2008/s:108"}], "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t (", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "122 Stat. 3509", "@value": "statute-at-large/122/3509"}], "@entity-type": "law-citation", "#text": "\n                "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n            ", "@id": "HF8CF629D43804A43B4074B5ADF7509FD"}], "#text": "\n          ", "@id": "H78D3CC7073B5433A9CE67A75E6774EF5"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Effective November 18, 2003, ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 5 of the\n\t\t\t Animal Drug User Fee Act of 2003", "@value": "Animal Drug User Fee Act of 2003/s:5"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "public-law", "#text": "Public Law 108\u2013130", "@value": "public-law/108/130"}, "@parsable-cite": "pl/108/130", "#text": "\n                ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n          ", "#text": "(d)"}, "header": {"#tail": "\n          ", "#text": "Technical\n\t\t\t clarification"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "HFD82329351614A6C94079BC25B75CA37", "@commented": "no"}], "#text": "\n        ", "@id": "H98B3FB34ADE143CB984081514FA7F305"}], "enum": {"#tail": "\n      ", "#text": "I"}, "header": {"#tail": "\n\t\t\t", "#text": "Animal Drug User Fee\n\t\t\t Amendments"}, "#text": "\n      ", "@id": "H697D085308F348A1A36267CB66E55E5E"}, {"#tail": "\n  ", "section": [{"@section-type": "section-one", "#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "201."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Short title;\n\t\t\t finding"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Animal Generic Drug\n\t\t\t User Fee Amendments of 2013", "@value": "Animal Generic Drug User Fee Amendments of 2013", "@proposed": "true"}, "#text": "\n              "}, "#text": "This title may be cited as the "}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Short\n\t\t\t title"}, "#text": "\n          ", "@id": "H1383DF0B08D74394B2FB52CF72031AED"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t to the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Chairman of the Committee on Energy and Commerce of the House of\n\t\t\t Representatives", "@entity-id": "HIF00"}, {"#tail": " as set forth in the Congressional Record.", "@entity-type": "committee", "#text": "Chairman of the Committee on Health, Education, Labor,\n\t\t\t and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "The fees authorized by this title will be\n\t\t\t dedicated toward expediting the generic new animal drug development process and\n\t\t\t the review of abbreviated applications for generic new animal drugs,\n\t\t\t supplemental abbreviated applications for generic new animal drugs, and\n\t\t\t investigational submissions for generic new animal drugs as set forth in the\n\t\t\t goals identified in the letters from the "}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Finding"}, "#text": "\n          ", "@id": "H96C2F49A68D543EDB6415BE06A705461", "@commented": "no"}], "#text": "\n        ", "@id": "H264F43CF92334A8D98B1B02F32C4E877"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 741 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201321", "@value": "usc/21/379j\u201321"}, "@parsable-cite": "usc/21/379j-21", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "202."}, "header": {"#tail": "\n        ", "#text": "Authority to assess\n\t\t\t and use generic new animal drug fees"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "741."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Authority to assess\n\t\t\t\tand use generic new animal drug fees"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tshall assess and collect fees in accordance with this section as\n\t\t\t\tfollows:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Beginning with respect to fiscal year 2009, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Types of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for such an application.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "Each person that submits, on or after July 1, 2008, an\n\t\t\t\tabbreviated application for a generic new animal drug shall be subject to a fee\n\t\t\t\tas established in "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                  ", "@id": "HBC908D12D31045F2AC2BC4159DD45236"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be due upon submission of the\n\t\t\t\tabbreviated application.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tfee required by "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment"}, "#text": "\n                  ", "@id": "HA962123A7DD64F82A122C4F82D1B5567"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:A", "@proposed": "true"}, "#text": "If an abbreviated application was submitted by a\n\t\t\t\tperson that paid the fee for such application, was accepted for filing, and was\n\t\t\t\tnot approved or was withdrawn (without a waiver or refund), the submission of\n\t\t\t\tan abbreviated application for the same product by the same person (or the\n\t\t\t\tperson\u2019s licensee, assignee, or successor) shall not be subject to a fee under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "header": {"#tail": "\n                    ", "#text": "Previously filed\n\t\t\t\tapplication"}, "#text": "\n                    ", "@id": "H2E574013BF3A461180FF7AFE56908AB6"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and\n\t\t\t\tsubmitted on or after October 1, 2013, shall be subject to a fee equal to 50\n\t\t\t\tpercent of the amount of the abbreviated application fee established in\n\t\t\t\t", "@entity-type": "act", "#text": "section 512(d)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:4"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}], "#text": "An\n\t\t\t\tabbreviated application for an animal drug described in "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "header": {"#tail": "\n                    ", "#text": "Certain abbreviated\n\t\t\t\tapplications involving combination animal drugs"}, "#text": "\n                    ", "@id": "HCEA535DC29EE4C54A637D84ABBB2BB16"}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Exceptions"}, "#text": "\n                  ", "@id": "H93C5714BFAC84DDE95129C2A91BAE77C"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall refund 75\n\t\t\t\tpercent of the fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " for any abbreviated application\n\t\t\t\twhich is refused for filing.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if\n\t\t\t\tapplication refused for filing"}, "#text": "\n                  ", "@id": "H1E8ABE30E52E44EBA1EFDF13F10F9ED7"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may refund the fee or portion of\n\t\t\t\tthe fee paid under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " if no substantial work was performed on the\n\t\t\t\tapplication after the application was filed. The ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1/sp:B", "@proposed": "true"}, {"#tail": " shall have the sole\n\t\t\t\tdiscretion to refund the fee under this subparagraph. A determination by the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " concerning a refund under this subparagraph shall not be\n\t\t\t\treviewable.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "If an abbreviated application is withdrawn\n\t\t\t\tafter the application was filed, the "}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "header": {"#tail": "\n                  ", "#text": "Refund of fee if\n\t\t\t\tapplication withdrawn"}, "#text": "\n                  ", "@id": "H0F64DC7E45AB4B599270C7230E19A4F4"}], "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Abbreviated application\n\t\t\t\tfee"}, "#text": "\n                ", "@id": "H8BC7B2B93423473298065C4FDBFF126B"}, {"#tail": "\n              ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall pay for each such generic new\n\t\t\t\tanimal drug product the annual fee established in "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who is named as the\n\t\t\t\tapplicant in an abbreviated application or supplemental abbreviated application\n\t\t\t\tfor a generic new animal drug product which has been submitted for listing\n\t\t\t\tunder section 510; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HD70D952523744CF1A8FD80E6A7FFA1BB", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application or\n\t\t\t\tsupplemental abbreviated application,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1,\n\t\t\t\t2008, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HC966D800BE0645F79605A86BE9D66A67", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "H5054493581E4462D87FFFBC6E4E0A55B"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day\n\t\t\t\tafter the date of enactment of an appropriations Act providing for the\n\t\t\t\tcollection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H6F9ABBB32EAB4210925CD0FE7C16CC76", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HD8B81772FE69493D9538181A60D81937", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee due\n\t\t\t\tdate"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or is submitted for relisting under ", "@entity-type": "act", "#text": "section\n\t\t\t\t510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}, {"#tail": " if the generic new animal\n\t\t\t\tdrug product has been withdrawn from listing and relisted. After such fee is\n\t\t\t\tpaid for that fiscal year, such fee shall be due each subsequent fiscal year\n\t\t\t\tthat the product remains listed, upon the later of\u2014", "@entity-type": "act", "#text": "section 510", "@value": "Federal Food, Drug, and Cosmetic Act/s:510"}], "#text": "Such fee shall be payable for the fiscal year in which the\n\t\t\t\tgeneric new animal drug product is first submitted for listing under "}, "#text": "\n                  ", "@id": "H3E0114D996C14181A4F8C5AC526ED610"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Such\n\t\t\t\tfee shall be paid only once for each generic new animal drug product for a\n\t\t\t\tfiscal year in which the fee is payable."}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Limitation"}, "#text": "\n                  ", "@id": "HF7886196915741009F8CE086000D79C5"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new animal drug\n\t\t\t\tproduct fee"}, "#text": "\n                ", "@id": "HFD34B13C617549BFACC5DDC4F2B85FD5"}, {"#tail": "\n            ", "subparagraph": [{"continuation-text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "@continuation-text-level": "subparagraph", "#text": "shall be assessed an annual generic new\n\t\t\t\tanimal drug sponsor fee as established under "}, "#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "who meets the definition\n\t\t\t\tof a generic new animal drug sponsor within a fiscal year; and"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HC4A5BF2C91DF4AFBB38C54CEF7A472DE", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " an abbreviated application, a\n\t\t\t\tsupplemental abbreviated application, or an investigational submission,", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "who, after September 1,\n\t\t\t\t2008, had pending before the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H6718F668A5534B279021B4CCC48F4BB0", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each person\u2014"}, "#text": "\n                  ", "@id": "H12FCFD407E654A12978811FBAB218C66"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the first business day\n\t\t\t\tafter the date of enactment of an appropriations Act providing for the\n\t\t\t\tcollection and obligation of fees for such fiscal year under this section;\n\t\t\t\tor"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H95A6C0274D744193A68422BDA46D9A5A", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "January 31 of each\n\t\t\t\tyear."}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H35DEA4A3AD9A4F67878239C00AE710C8", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Payment; fee due\n\t\t\t\tdate"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Such fee shall be due each fiscal year upon the later\n\t\t\t\tof\u2014"}, "#text": "\n                  ", "@id": "HFDAF3B794240405F84CF295A3E5FCC4D"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 6 approved abbreviated\n\t\t\t\tapplications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "100 percent of the amount\n\t\t\t\tof the generic new animal drug sponsor fee published for that fiscal year under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H8BC4FEE501044243AAC938ACAAFC6742", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with more than 1 and fewer than 7 approved\n\t\t\t\tabbreviated applications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "75 percent of the amount\n\t\t\t\tof the generic new animal drug sponsor fee published for that fiscal year under\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H9C8258C52DBF479F8FBFF4FBC73E4C46", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for an applicant with 1 or fewer approved abbreviated\n\t\t\t\tapplications.", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, "#text": "50 percent of the\n\t\t\t\tamount of the generic new animal drug sponsor fee published for that fiscal\n\t\t\t\tyear under "}, "enum": {"#tail": "\n                    ", "#text": "(iii)"}, "@id": "H0971EBBD9653465DA0ED721D8943F13A", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Amount of\n\t\t\t\tfee"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Each generic new animal drug sponsor shall pay only 1 such\n\t\t\t\tfee each fiscal year, as follows:"}, "#text": "\n                  ", "@id": "HA95AA17C8C1D47BDBF948B59C1A70044"}], "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Generic new animal drug\n\t\t\t\tsponsor fee"}, "#text": "\n                ", "@id": "H0B8D6C49A736491B8D802EAB4597AC16"}], "#text": "\n              ", "@id": "H7EEC61DDC47B429986C4EB8ED2360D57"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsections (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:c", "@proposed": "true"}, {"#tail": ", ", "@entity-type": "act", "#text": "(d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", and ", "@entity-type": "act", "#text": "(f)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f", "@proposed": "true"}, {"#tail": ", the fees\n\t\t\t\trequired under ", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g", "@proposed": "true"}, {"#tail": " shall be established to generate fee revenue\n\t\t\t\tamounts as follows:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "Subject to "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fee\n\t\t\t\tamounts"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be $1,832,000 for\n\t\t\t\tfiscal year 2014, $1,736,000 for fiscal year 2015, $1,857,000 for fiscal year\n\t\t\t\t2016, $1,984,000 for fiscal year 2017, and $2,117,000 for fiscal year\n\t\t\t\t2018.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:1", "@proposed": "true"}, "#text": "The total fee revenues to be collected in\n\t\t\t\tabbreviated application fees under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for\n\t\t\t\tapplication fees"}, "#text": "\n                ", "@id": "H8454A6A807F34ECF8171190DBA8BAE83"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be $2,748,000 for\n\t\t\t\tfiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000 for fiscal year\n\t\t\t\t2016, $2,976,000 for fiscal year 2017, and $3,175,000 for fiscal year\n\t\t\t\t2018.", "@entity-type": "act", "#text": "subsection (a)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:2", "@proposed": "true"}, "#text": "The total fee revenues to be collected in generic\n\t\t\t\tnew animal drug product fees under "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for\n\t\t\t\tproduct fees"}, "#text": "\n                ", "@id": "HC3114FDD233448218F66F631DDF113DF"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be $2,748,000 for\n\t\t\t\tfiscal year 2014, $2,604,000 for fiscal year 2015, $2,786,000 for fiscal year\n\t\t\t\t2016, $2,976,000 for fiscal year 2017, and $3,175,000 for fiscal year\n\t\t\t\t2018.", "@entity-type": "act", "#text": "subsection (a)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a/p:3", "@proposed": "true"}, "#text": "The total fee revenues to be collected in generic\n\t\t\t\tnew animal drug sponsor fees under "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Total fee revenues for\n\t\t\t\tsponsor fees"}, "#text": "\n                ", "@id": "HBA7C3D3C1A9A48B78BE06DADA649C5AE"}], "#text": "\n              ", "@id": "HFF1C8B6668A04A51B4FB0C5A4429CD59"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Annual fee setting;\n\t\t\t\tadjustments"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall establish, 60 days before the start\n\t\t\t\tof each fiscal year beginning after September 30, 2008, for that fiscal year,\n\t\t\t\tabbreviated application fees, generic new animal drug sponsor fees, and generic\n\t\t\t\tnew animal drug product fees, based on the revenue amounts established under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the adjustments provided under this subsection.", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Annual fee\n\t\t\t\tsetting"}, "#text": "\n                ", "@id": "H305EAF44DFE144D4BB98715C3716B4B1"}, {"#tail": "\n              ", "@id": "HB602349E6295496DBE26DE41342519F7", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Workload\n\t\t\t\tadjustment"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The fee revenues shall be adjusted each fiscal year\n\t\t\t\tafter fiscal year 2014 to reflect changes in review workload. With respect to\n\t\t\t\tsuch adjustment:"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based on a weighted average of the change in the\n\t\t\t\ttotal number of abbreviated applications for generic new animal drugs,\n\t\t\t\tmanufacturing supplemental abbreviated applications for generic new animal\n\t\t\t\tdrugs, investigational generic new animal drug study submissions, and\n\t\t\t\tinvestigational generic new animal drug protocol submissions submitted to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall publish in the Federal Register the fees\n\t\t\t\tresulting from this adjustment and the supporting methodologies.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "This adjustment shall be\n\t\t\t\tdetermined by the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H8742F207840C476B9887D2EE8C74DC88", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:b", "@proposed": "true"}, "#text": "Under no circumstances\n\t\t\t\tshall this workload adjustment result in fee revenues for a fiscal year that\n\t\t\t\tare less than the fee revenues for that fiscal year established in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H4D85D3E2BA8048EB91D780C0F5F86C5A", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in addition\n\t\t\t\tto other adjustments under this subsection, further increase the fees under\n\t\t\t\tthis section, if such an adjustment is necessary, to provide for up to 3 months\n\t\t\t\tof operating reserves of carryover user fees for the process for the review of\n\t\t\t\tabbreviated applications for generic new animal drugs for the first 3 months of\n\t\t\t\tfiscal year 2019. If the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has carryover balances\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs in excess of 3 months of such operating reserves, then this\n\t\t\t\tadjustment shall not be made. If this adjustment is necessary, then the\n\t\t\t\trationale for the amount of the increase shall be contained in the annual\n\t\t\t\tnotice setting fees for fiscal year 2018.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "For fiscal year 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Final year\n\t\t\t\tadjustment"}, "#text": "\n                ", "@id": "HBDE6BB74CA9C4690AD48E07E6C331DF1"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\ttotal amount of fees charged, as adjusted under this subsection, for a fiscal\n\t\t\t\tyear may not exceed the total costs for such fiscal year for the resources\n\t\t\t\tallocated for the process for the review of abbreviated applications for\n\t\t\t\tgeneric new animal drugs."}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Limit"}, "#text": "\n                ", "@id": "HF27006639EFB4BDFB3474958C4F8D8F8"}], "#text": "\n              ", "@id": "H79422AEDC50B4550BED76882F9AE9F22"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall grant a waiver from or a reduction\n\t\t\t\tof 1 or more fees assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " where the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " finds that\n\t\t\t\tthe generic new animal drug is intended solely to provide for a minor use or\n\t\t\t\tminor species indication.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n              ", "#text": "Fee waiver or\n\t\t\t\treduction"}, "#text": "\n              ", "@id": "H7455F86D37BF4EEF8C517D8FA3B90561"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered\n\t\t\t\tincomplete and shall not be accepted for filing by the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " until all fees\n\t\t\t\towed by such person have been paid. An investigational submission for a generic\n\t\t\t\tnew animal drug that is submitted by a person subject to fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall be considered incomplete and shall not be accepted for review by the\n\t\t\t\tSecretary until all fees owed by such person have been paid. The ", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " may\n\t\t\t\tdiscontinue review of any abbreviated application for a generic new animal\n\t\t\t\tdrug, supplemental abbreviated application for a generic new animal drug, or\n\t\t\t\tinvestigational submission for a generic new animal drug from a person if such\n\t\t\t\tperson has not submitted for payment all fees owed under this section by 30\n\t\t\t\tdays after the date upon which they are due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "An abbreviated application for a generic new animal drug\n\t\t\t\tsubmitted by a person subject to fees under "}, "enum": {"#tail": "\n              ", "#text": "(e)"}, "header": {"#tail": "\n              ", "#text": "Effect of failure To\n\t\t\t\tpay fees"}, "#text": "\n              ", "@id": "H9EA09270868E4F5CB8254156B12B57BB"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Assessment of\n\t\t\t\tfees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a fiscal year beginning after\n\t\t\t\tfiscal year 2008 unless appropriations for salaries and expenses of the Food\n\t\t\t\tand Drug Administration for such fiscal year (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) are equal to or greater than the amount of\n\t\t\t\tappropriations for the salaries and expenses of the Food and Drug\n\t\t\t\tAdministration for the fiscal year 2003 (excluding the amount of fees\n\t\t\t\tappropriated for such fiscal year) multiplied by the adjustment factor\n\t\t\t\tapplicable to the fiscal year involved.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, "#text": "Fees\n\t\t\t\tmay not be assessed under "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Limitation"}, "#text": "\n                ", "@id": "H428DA3083B494E5193B948220D9E26D5"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not assess fees under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " during any portion of a\n\t\t\t\tfiscal year because of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " and if at a later date in such fiscal year\n\t\t\t\tthe ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, {"#tail": " may assess such fees, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may assess and collect such\n\t\t\t\tfees, without any modification in the rate, for abbreviated applications,\n\t\t\t\tgeneric new animal drug sponsors, and generic new animal drug products at any\n\t\t\t\ttime in such fiscal year notwithstanding the provisions of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t\trelating to the date fees are to be paid.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Authority"}, "#text": "\n                ", "@id": "HEAA5558D751642FD8CE9C162D0EA038E"}], "#text": "\n              ", "@id": "HFFEE44A4439C4B0383A878E978DDE23C"}, {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "(g)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Crediting and\n\t\t\t\tavailability of fees"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", fees authorized under\n\t\t\t\t", "@entity-type": "act", "#text": "paragraph (2)(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, {"#tail": " shall be collected and available for obligation only to the\n\t\t\t\textent and in the amount provided in advance in appropriations Acts. Such fees\n\t\t\t\tare authorized to be appropriated to remain available until expended. Such sums\n\t\t\t\tas may be necessary may be transferred from the ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": "\n\t\t\t\tsalaries and expenses appropriation account without fiscal year limitation to\n\t\t\t\tsuch appropriation account for salary and expenses with such fiscal year\n\t\t\t\tlimitation. The sums transferred shall be available solely for the process for\n\t\t\t\tthe review of abbreviated applications for generic new animal drugs.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Subject to "}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n                ", "@id": "H5B934D23F45743F7A8E3839F783F76A2"}, {"#tail": "\n              ", "subparagraph": [{"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", shall be collected and available in each fiscal year in an amount not to\n\t\t\t\texceed the amount specified in appropriation Acts, or otherwise made available\n\t\t\t\tfor obligation for such fiscal year; and", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(C)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:C", "@proposed": "true"}, "#text": "subject to "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H900B251EA650403789D6C4B6E19DB793", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to be engaged in such\n\t\t\t\tprocess) over such costs, excluding costs paid from fees collected under this\n\t\t\t\tsection, for fiscal year 2008 multiplied by the adjustment factor.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "shall be available to\n\t\t\t\tdefray increases in the costs of the resources allocated for the process for\n\t\t\t\tthe review of abbreviated applications for generic new animal drugs (including\n\t\t\t\tincreases in such costs for an additional number of full-time equivalent\n\t\t\t\tpositions in the "}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HFCCE613B6DCB48C3AA49D82B821E5105", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "In\n\t\t\t\tgeneral"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The fees authorized by this section\u2014"}, "#text": "\n                  ", "@id": "HC0763E96CDA14C0BAAC39FA26C47AE86"}, {"#tail": "\n                ", "clause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "are not more than 3\n\t\t\t\tpercent below the level specified in "}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "HAEE3F86147E648AA977A433A4BE8902B", "#text": "\n                    "}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", and fees assessed for the\n\t\t\t\tfiscal year following the subsequent fiscal year are decreased by the amount in\n\t\t\t\texcess of 3 percent by which such costs fell below the level specified in\n\t\t\t\t", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "are more than 3 percent\n\t\t\t\tbelow the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                      ", "@id": "H2F34518399974005AA219C2F38C61847", "@commented": "no"}, {"@committee-id": "HIF00", "@changed": "added", "@indent": "up1", "#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "such costs are not more\n\t\t\t\tthan 5 percent below the level specified in "}, "enum": {"#tail": "\n                      ", "#text": "(II)"}, "@reported-display-style": "italic", "#text": "\n                      ", "@id": "H95A0AC9977A245E8933814C87A0095AF"}], "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "H31B3E4E8221F4B50BDDE1DB40953CDE4", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Compliance"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be considered to have met the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in any fiscal year if the costs funded by appropriations and allocated\n\t\t\t\tfor the process for the review of abbreviated applications for generic new\n\t\t\t\tanimal drugs\u2014", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "#text": "\n                  ", "@id": "H0054EF2733664BD3BD7935055974C1DD"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in accordance with authority provided in advance in a prior year\n\t\t\t\tappropriations Act.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Payment of fees authorized under this section for a\n\t\t\t\tfiscal year, prior to the due date for such fees, may be accepted by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "header": {"#tail": "\n                  ", "#text": "Provision for early\n\t\t\t\tpayments"}, "#text": "\n                  ", "@id": "HDC9175E648F4439F92C7A938F2DAF37E"}], "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Collections and\n\t\t\t\tappropriation acts"}, "#text": "\n                ", "@id": "HEDC238A16EC44821B8240967679077A8"}, {"continuation-text": {"#tail": "\n              ", "@continuation-text-level": "paragraph", "#text": "as\n\t\t\t\tadjusted to reflect adjustments in the total fee revenues made under this\n\t\t\t\tsection and changes in the total amounts collected by abbreviated application\n\t\t\t\tfees, generic new animal drug sponsor fees, and generic new animal drug product\n\t\t\t\tfees."}, "#tail": "\n              ", "@id": "HC5EA695E22A54BEFA612E3CF29B21493", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Authorization of\n\t\t\t\tappropriations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "\n                There are authorized to be appropriated ", "{http://namespaces.cato.org/catoxml}property": {"#tail": "\u2014\n              ", "#text": "for fees\n\t\t\t\tunder this section", "@name": "purpose"}}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "#text": "\n                  ", "@id": "H6CA72CACF8194AB7862667291FC824C7", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,328,000 for fiscal\n\t\t\t\tyear 2014", "@amount": "7328000", "@year": "2014"}, "#text": "\n                      "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(A)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "H5F561141FBBF4BFB903B8D6FFBA38451", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$6,944,000 for fiscal\n\t\t\t\tyear 2015", "@amount": "6944000", "@year": "2015"}, "#text": "\n                      "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(B)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "H9DBA9E510B874E12AEF511D6FBB4C464", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$7,429,000 for fiscal\n\t\t\t\tyear 2016", "@amount": "7429000", "@year": "2016"}, "#text": "\n                      "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(C)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "H62B321C7A63C400D98B58632C20E5C45", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": "; and", "#text": "$7,936,000 for fiscal\n\t\t\t\tyear 2017", "@amount": "7936000", "@year": "2017"}, "#text": "\n                      "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(D)"}, "#text": "\n                    "}}, {"#tail": "\n                ", "#text": "\n                  ", "@id": "H7F10882498B64FD4B0A7216E271DF935", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n\t\t\t\t\t\t\t\t", "text": {"#tail": "\n                  ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ";", "#text": "$8,467,000 for fiscal\n\t\t\t\tyear 2018", "@amount": "8467000", "@year": "2018"}, "#text": "\n                      "}, "@entity-type": "auth-auth-approp", "enum": {"#tail": "\n                  ", "#text": "(E)"}, "#text": "\n                    "}}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " for the fiscal years 2014 through 2017, the\n\t\t\t\texcess amount shall be credited to the appropriation account of the ", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:3", "@proposed": "true"}, {"#tail": " as provided in ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}, {"#tail": ", and shall be subtracted from\n\t\t\t\tthe amount of fees that would otherwise be authorized to be collected under\n\t\t\t\tthis section pursuant to appropriation Acts for fiscal year 2018.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:1", "@proposed": "true"}], "#text": "If\n\t\t\t\tthe sum of the cumulative amount of fees collected under this section for the\n\t\t\t\tfiscal years 2014 through 2016 and the amount of fees estimated to be collected\n\t\t\t\tunder this section for fiscal year 2017 exceeds the cumulative amount\n\t\t\t\tappropriated under "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Offset"}, "#text": "\n                ", "@id": "HBDD0FABEDC614083B49A63D1A9EE20C1"}], "#text": "\n              ", "@id": "H6CD3E77F2E59413B8FD33B313E169CA1"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " does not receive payment of\n\t\t\t\ta fee assessed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " within 30 days after it is due, such fee\n\t\t\t\tshall be treated as a claim of the United States Government subject to\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": ".", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc-chapter/31/37", "#text": "chapter 37", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/31/37/II"}], "#text": "In any case where the "}, "enum": {"#tail": "\n              ", "#text": "(h)"}, "header": {"#tail": "\n              ", "#text": "Collection of unpaid\n\t\t\t\tfees"}, "#text": "\n              ", "@id": "H6FC4E9BF7F0D48748FBEF456EBDB5450"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or for a refund of any fee\n\t\t\t\tcollected in accordance with ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:d", "@proposed": "true"}, {"#tail": ", a person shall submit to the\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:a", "@proposed": "true"}, {"#tail": " a written request for such waiver, reduction, or refund not later\n\t\t\t\tthan 180 days after such fee is due.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "To qualify for consideration for\n\t\t\t\ta waiver or reduction under "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "header": {"#tail": "\n              ", "#text": "Written requests for\n\t\t\t\twaivers, reductions, and refunds"}, "#text": "\n              ", "@id": "H53305811A0E04420BEA7A08CD880A53C"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", for officers,\n\t\t\t\temployees, and advisory committees not engaged in the process of the review of\n\t\t\t\tabbreviated applications for generic new animal drugs, be reduced to offset the\n\t\t\t\tnumber of officers, employees, and advisory committees so engaged.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}, "#text": "This\n\t\t\t\tsection may not be construed to require that the number of full-time equivalent\n\t\t\t\tpositions in the "}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "header": {"#tail": "\n              ", "#text": "Construction"}, "#text": "\n              ", "@id": "HED9A15E7E363462D9ADD27DB179EDFD8"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ":", "@entity-type": "act", "#text": "section 742", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "#text": "In\n\t\t\t\tthis section and "}, "enum": {"#tail": "\n              ", "#text": "(k)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and ", "#text": "abbreviated\n\t\t\t\tapplication for a generic new animal drug"}, {"#tail": " mean an abbreviated application for the approval of any\n\t\t\t\tgeneric new animal drug submitted under ", "#text": "abbreviated\n\t\t\t\tapplication"}], "#text": "The terms ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Such term does not\n\t\t\t\tinclude a supplemental abbreviated application for a generic new animal\n\t\t\t\tdrug.", "@entity-type": "act", "#text": "section 512(b)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:b/p:2"}}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Abbreviated application\n\t\t\t\tfor a generic new animal drug"}, "#text": "\n                ", "@id": "HC4212EAC87344501A23ABA46434BEAE1"}, {"#tail": "\n              ", "@id": "H05CB296EE9384D98B81E20BA3F9C0A97", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Adjustment\n\t\t\t\tfactor"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " applicable to a\n\t\t\t\tfiscal year is the Consumer Price Index for all urban consumers (all items;\n\t\t\t\tUnited States city average) for October of the preceding fiscal year divided\n\t\t\t\tby\u2014", "#text": "adjustment factor"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2002; and", "@entity-type": "act", "#text": "subsection (f)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:f/p:1", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HF666AF2CF1E141DC868A43A9B0DB90B3", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", such Index for October 2007.", "@entity-type": "act", "#text": "subsection (g)(2)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:741/ss:g/p:2/sp:A/cl:ii", "@proposed": "true"}, "#text": "for purposes of\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H9A2DECDEF28A46149FCDB1F6DC9D7752", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "HA7CDC64A0D70448A8FDF60B5CC9C79F7", "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Costs of resources\n\t\t\t\tallocated for the process for the review of abbreviated applications for\n\t\t\t\tgeneric new animal drugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means the expenses in connection with the\n\t\t\t\tprocess for the review of abbreviated applications for generic new animal drugs\n\t\t\t\tfor\u2014", "#text": "costs of resources\n\t\t\t\tallocated for the process for the review of abbreviated applications for\n\t\t\t\tgeneric new animal drugs"}, "#text": "The term "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", contractors of the Food and Drug\n\t\t\t\tAdministration, advisory committees consulted with respect to the review of\n\t\t\t\tspecific abbreviated applications, supplemental abbreviated applications, or\n\t\t\t\tinvestigational submissions, and costs related to such officers, employees,\n\t\t\t\tcommittees, and contractors, including costs for travel, education, and\n\t\t\t\trecruitment and other personnel activities;", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "officers and employees of\n\t\t\t\tthe "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HA4C5C10B6FB347FD9218FC0BBD561DE6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "management of\n\t\t\t\tinformation, and the acquisition, maintenance, and repair of computer\n\t\t\t\tresources;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H0ADFE85E78B542389B186AE1DC4A941F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "leasing, maintenance,\n\t\t\t\trenovation, and repair of facilities and acquisition, maintenance, and repair\n\t\t\t\tof fixtures, furniture, scientific equipment, and other necessary materials and\n\t\t\t\tsupplies; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H6AD3F95943B643DA8DAF154637716464", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "collecting fees under\n\t\t\t\tthis section and accounting for resources allocated for the review of\n\t\t\t\tabbreviated applications, supplemental abbreviated applications, and\n\t\t\t\tinvestigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H46BCF2D2B5DC470ABBE22B9C0A40BC87", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means, with respect\n\t\t\t\tto a generic new animal drug product, a finished dosage form which is approved\n\t\t\t\tfor administration to an animal without substantial further manufacturing. Such\n\t\t\t\tterm includes generic new animal drug products intended for mixing in animal\n\t\t\t\tfeeds.", "#text": "final dosage form"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Final dosage\n\t\t\t\tform"}, "#text": "\n                ", "@id": "HC08A320770374791A0C552624B10640C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a new\n\t\t\t\tanimal drug that is the subject of an abbreviated application.", "#text": "generic new animal drug"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal\n\t\t\t\tdrug"}, "#text": "\n                ", "@id": "H02B19E83A77C4CFDAB2C77FFF9423DF1"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": "\n\t\t\t\tmeans each specific strength or potency of a particular active ingredient or\n\t\t\t\tingredients in final dosage form marketed by a particular manufacturer or\n\t\t\t\tdistributor, which is uniquely identified by the labeler code and product code\n\t\t\t\tportions of the national drug code, and for which an abbreviated application\n\t\t\t\tfor a generic new animal drug or a supplemental abbreviated application has\n\t\t\t\tbeen approved.", "#text": "generic new animal drug product"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal drug\n\t\t\t\tproduct"}, "#text": "\n                ", "@id": "H5A4B8A06A4514E4D8E21B11EF810A7A6"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", or a person who has submitted an\n\t\t\t\tinvestigational submission for a generic new animal drug that has not been\n\t\t\t\tterminated or otherwise rendered inactive by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "term": {"#tail": "\n\t\t\t\tmeans either an applicant named in an abbreviated application for a generic new\n\t\t\t\tanimal drug that has not been withdrawn by the applicant and for which approval\n\t\t\t\thas not been withdrawn by the ", "#text": "generic new animal drug sponsor"}, "#text": "The term "}, "enum": {"#tail": "\n                ", "#text": "(7)"}, "header": {"#tail": "\n                ", "#text": "Generic new animal drug\n\t\t\t\tsponsor"}, "#text": "\n                ", "@id": "HAFB2A1A674664BDC9E7F0BF927F49AE9"}, {"#tail": "\n              ", "@id": "HF39DC0FC19E74EA19630D2FECC5754AA", "enum": {"#tail": "\n                ", "#text": "(8)"}, "header": {"#tail": "\n                ", "#text": "Investigational\n\t\t\t\tsubmission for a generic new animal drug"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "quote": {"#tail": " mean\u2014", "#text": "investigational submission"}, "term": {"#tail": " and\n\t\t\t\t", "#text": "investigational submission for a generic new animal drug"}, "#text": "The terms\n\t\t\t\t"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " for a generic new animal drug\n\t\t\t\tintended to be the subject of an abbreviated application or a supplemental\n\t\t\t\tabbreviated application; or", "@entity-type": "act", "#text": "section 512(j)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:j"}, "#text": "the filing of a claim for\n\t\t\t\tan investigational exemption under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HE18A7834F3D8451ABF4BC745F51126E9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to evaluate the safety or\n\t\t\t\teffectiveness of a generic new animal drug in the event of the filing of an\n\t\t\t\tabbreviated application or supplemental abbreviated application for such\n\t\t\t\tdrug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the submission of\n\t\t\t\tinformation for the purpose of enabling the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H6954C49B066F4EEA9C8790D1D0C238BA", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ").", "@entity-type": "act", "#text": "section 735(11)", "@value": "Federal Food, Drug, and Cosmetic Act/s:735/p:11"}, "term": {"#tail": " includes an affiliate thereof (as such term is defined\n\t\t\t\tin ", "#text": "person"}, "#text": "The\n\t\t\t\tterm "}, "enum": {"#tail": "\n                ", "#text": "(9)"}, "header": {"#tail": "\n                ", "#text": "Person"}, "#text": "\n                ", "@id": "HB686E7A08B8F4CD18271E57A19939BC7"}, {"#tail": "\n              ", "@id": "HFA819836FB384A67B3E679BB4F3D0F0F", "enum": {"#tail": "\n                ", "#text": "(10)"}, "header": {"#tail": "\n                ", "#text": "Process for the review\n\t\t\t\tof abbreviated applications for generic new animal drugs"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect to\n\t\t\t\tthe review of abbreviated applications, supplemental abbreviated applications,\n\t\t\t\tand investigational submissions:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": {"#tail": " means the following activities of the ", "#text": "process for the review of abbreviated applications for generic new animal\n\t\t\t\tdrugs"}, "#text": "The term\n\t\t\t\t"}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The activities necessary\n\t\t\t\tfor the review of abbreviated applications, supplemental abbreviated\n\t\t\t\tapplications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HF8FB9B03AA124DF79A79087452F960DD", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The issuance of action\n\t\t\t\tletters which approve abbreviated applications or supplemental abbreviated\n\t\t\t\tapplications or which set forth in detail the specific deficiencies in\n\t\t\t\tabbreviated applications, supplemental abbreviated applications, or\n\t\t\t\tinvestigational submissions and, where appropriate, the actions necessary to\n\t\t\t\tplace such applications, supplemental applications, or submissions in condition\n\t\t\t\tfor approval."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HBF2514551E4A412997930F74CB2D4A29", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " review of pending abbreviated applications, supplemental\n\t\t\t\tabbreviated applications, and investigational submissions.", "@entity-type": "federal-body", "#text": "Secretary\u2019s", "@entity-id": "7500"}, "#text": "The inspection of generic\n\t\t\t\tnew animal drug establishments and other facilities undertaken as part of the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "HFB36B6EA6A974AEEAA9CECCEC8CCDC14", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Monitoring of research\n\t\t\t\tconducted in connection with the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H03DB435A2EBE4D7DAD4C6E851849B4CC", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The development of\n\t\t\t\tregulations and policy related to the review of abbreviated applications,\n\t\t\t\tsupplemental abbreviated applications, and investigational submissions."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H3CD3AB565E7149E9B3B78AB8F5F98FBC", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Development of standards\n\t\t\t\tfor products subject to review."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "HA4A5C4210A484302B0CF83D49A3A61AB", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Meetings between the\n\t\t\t\tagency and the generic new animal drug sponsor."}, "enum": {"#tail": "\n                  ", "#text": "(G)"}, "@id": "H0149F54A52E64638B74FBCB2D0C6D972", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Review of advertising and\n\t\t\t\tlabeling prior to approval of an abbreviated application or supplemental\n\t\t\t\tabbreviated application, but not after such application has been\n\t\t\t\tapproved."}, "enum": {"#tail": "\n                  ", "#text": "(H)"}, "@id": "HA50AC19898A844FEBD572C4082529C15", "#text": "\n                  "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "quote": [{"#tail": " and ", "#text": "supplemental abbreviated application for a generic new animal\n\t\t\t\tdrug"}, {"#tail": " mean a\n\t\t\t\trequest to the ", "#text": "supplemental abbreviated application"}], "#text": "The terms\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to approve a change in an approved abbreviated\n\t\t\t\tapplication.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}}, "enum": {"#tail": "\n                ", "#text": "(11)"}, "header": {"#tail": "\n                ", "#text": "Supplemental\n\t\t\t\tabbreviated application for generic new animal drug"}, "#text": "\n                ", "@id": "H76AD418EF2FD4530AF0C45637EC895DD"}], "#text": "\n              ", "@id": "H6C92FD26FC4B4377A900D92366D6A577"}], "#text": "\n            ", "@id": "H65576A16FC5B4F5BA58D4CDC0F772E48"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HF99F54679BE14B7C8721C9C896AE8422"}, "#text": "\n        ", "@id": "H3E09AE53D7654C4EAE8B90062929F6ED"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 742 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201322", "@value": "usc/21/379j\u201322"}, "@parsable-cite": "usc/21/379j-22", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "203."}, "header": {"#tail": "\n        ", "#text": "Reauthorization;\n\t\t\t reporting requirements"}, "quoted-block": {"@style": "OLC", "@committee-id": "HIF00", "@changed": "added", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "742."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reauthorization;\n\t\t\t\treporting requirements"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tHealth, Education, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report concerning the\n\t\t\t\tprogress of the ", "@entity-type": "committee", "#text": "Committee on\n\t\t\t\tEnergy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": " in achieving the goals identified\n\t\t\t\tin the letters described in ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " toward expediting the generic new animal drug development\n\t\t\t\tprocess and the review of abbreviated applications for generic new animal\n\t\t\t\tdrugs, supplemental abbreviated applications for generic new animal drugs, and\n\t\t\t\tinvestigational submissions for generic new animal drugs during such fiscal\n\t\t\t\tyear.", "@entity-type": "act", "#text": "section 201(b) of the Animal Generic Drug User Fee\n\t\t\t\tAmendments of 2013", "@value": "Animal Generic Drug User Fee Amendments of 2013/s:201/ss:b", "@proposed": "true"}], "#text": "Beginning with fiscal year 2014, not later\n\t\t\t\tthan 120 days after the end of each fiscal year during which fees are collected\n\t\t\t\tunder this part, the "}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Performance\n\t\t\t\treports"}, "#text": "\n              ", "@id": "H28884148BDEF4D508FF64912D1A6F312"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall prepare and submit to the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, {"#tail": " a report on the implementation of the\n\t\t\t\tauthority for such fees during such fiscal year and the use, by the ", "@entity-type": "committee", "#text": "Committee on Energy and\n\t\t\t\tCommerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", of the fees collected during such fiscal year for which\n\t\t\t\tthe report is made.", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t\tDrug Administration", "@entity-id": "7524"}], "#text": "Beginning with fiscal year 2014, not later than 120 days\n\t\t\t\tafter the end of each fiscal year during which fees are collected under this\n\t\t\t\tpart, the "}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Fiscal\n\t\t\t\treport"}, "#text": "\n              ", "@id": "H1C05DF7CE546424386C70C7B2CE78189"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make the reports required under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subsections (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, {"#tail": " available to the public on the Internet Web site of the\n\t\t\t\tFood and Drug Administration.", "@entity-type": "act", "#text": "(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:b", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(c)"}, "header": {"#tail": "\n              ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n              ", "@id": "HF9A8B7B7257E434286B5BF20F75B8D38"}, {"#tail": "\n          ", "enum": {"#tail": "\n              ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Reauthorization"}, "paragraph": [{"#tail": "\n              ", "@id": "H00F0E08CC8BD4558AD80190BB89D0C84", "enum": {"#tail": "\n                ", "#text": "(1)"}, "header": {"#tail": "\n                ", "#text": "Consultation"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " with respect to the goals,\n\t\t\t\tand plans for meeting the goals, for the process for the review of abbreviated\n\t\t\t\tapplications for generic new animal drugs for the first 5 fiscal years after\n\t\t\t\tfiscal year 2018, and for the reauthorization of this part for such fiscal\n\t\t\t\tyears, the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " shall consult with\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In\n\t\t\t\tdeveloping recommendations to present to "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Energy\n\t\t\t\tand Commerce of the House of Representatives", "@entity-id": "HIF00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HAB2231A05FBC4423A90FD16342332C93", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "committee", "#text": "Committee on Health,\n\t\t\t\tEducation, Labor, and Pensions of the Senate", "@entity-id": "SSHR00"}, "#text": "the "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H6E7C9CAB02A84CE5A8766B1300D8CFF4", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "scientific and academic\n\t\t\t\texperts;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H6D69F3F5745E4618B6277E4399B2058B", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "veterinary\n\t\t\t\tprofessionals;"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "HD667E9A42E174D01B690A7C06AF4CA1C", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "representatives of\n\t\t\t\tpatient and consumer advocacy groups; and"}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H3A67D8CC408244C8B19B5635CFBEE1F9", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the regulated\n\t\t\t\tindustry."}, "enum": {"#tail": "\n                  ", "#text": "(F)"}, "@id": "HD4628CC71CB04CA49812D17A75314EE6", "#text": "\n                  "}]}, {"#tail": "\n              ", "@id": "HB061671AC8A045AB8EE64AC0318006F8", "enum": {"#tail": "\n                ", "#text": "(2)"}, "header": {"#tail": "\n                ", "#text": "Prior public\n\t\t\t\tinput"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Prior to beginning negotiations with the regulated industry\n\t\t\t\ton the reauthorization of this part, the "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish a notice in the\n\t\t\t\tFederal Register requesting public input on the reauthorization;"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "H71AFCC31CEC44D6484A8324EF5CA3DAC", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:a", "@proposed": "true"}, "#text": "hold a public meeting at\n\t\t\t\twhich the public may present its views on the reauthorization, including\n\t\t\t\tspecific suggestions for changes to the goals referred to in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H2905BD1AA5BD4EBC8283C38AA8E241C1", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide a period of 30\n\t\t\t\tdays after the public meeting to obtain written comments from the public\n\t\t\t\tsuggesting changes to this part; and"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H4D0954B6F6DA4618810799F319B646AF", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish the comments on\n\t\t\t\tthe Food and Drug Administration\u2019s Internet Web site."}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H822FCDFD9FA84F1B8499BE2E650B935D", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall hold discussions\n\t\t\t\twith representatives of veterinary, patient, and consumer advocacy groups to\n\t\t\t\tcontinue discussions of their views on the reauthorization and their\n\t\t\t\tsuggestions for changes to this part as expressed under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:2", "@proposed": "true"}], "#text": "Not less frequently than once every 4 months during\n\t\t\t\tnegotiations with the regulated industry, the "}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "header": {"#tail": "\n                ", "#text": "Periodic\n\t\t\t\tconsultation"}, "#text": "\n                ", "@id": "H717343B8918E4F878146A8A7409B92FA"}, {"#tail": "\n              ", "@id": "H6F5798A53DAC4CBAA3E8A87D95E35BF8", "enum": {"#tail": "\n                ", "#text": "(4)"}, "header": {"#tail": "\n                ", "#text": "Public review of\n\t\t\t\trecommendations"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "After negotiations with the regulated industry,\n\t\t\t\tthe "}, "#text": "\n                ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the congressional committees\n\t\t\t\tspecified in such paragraph;", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1", "@proposed": "true"}, "#text": "present the\n\t\t\t\trecommendations developed under "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HCE6990599D484DE885C6EB10C6360401", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "publish such\n\t\t\t\trecommendations in the Federal Register;"}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H77859CB47142405BA398DF9578D67599", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide for a period of\n\t\t\t\t30 days for the public to provide written comments on such\n\t\t\t\trecommendations;"}, "enum": {"#tail": "\n                  ", "#text": "(C)"}, "@id": "H394B9FB0F924454B99C7A068E7201207", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "hold a meeting at which\n\t\t\t\tthe public may present its views on such recommendations; and"}, "enum": {"#tail": "\n                  ", "#text": "(D)"}, "@id": "H189457F059D9451EA61CB6DDEA380E42", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "after consideration of\n\t\t\t\tsuch public views and comments, revise such recommendations as\n\t\t\t\tnecessary."}, "enum": {"#tail": "\n                  ", "#text": "(E)"}, "@id": "H8EE0350C342545288B8774409C6B5748", "#text": "\n                  "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t\tshall transmit to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " the revised recommendations under ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ", a\n\t\t\t\tsummary of the views and comments received under such paragraph, and any\n\t\t\t\tchanges made to the recommendations in response to such views and\n\t\t\t\tcomments.", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:4", "@proposed": "true"}], "#text": "Not later than January 15, 2018, the "}, "enum": {"#tail": "\n                ", "#text": "(5)"}, "header": {"#tail": "\n                ", "#text": "Transmittal of\n\t\t\t\trecommendations"}, "#text": "\n                ", "@id": "HD1865FEB3CA0406E86066F3BBC007E99"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " to Congress, the ", "@entity-type": "act", "#text": "paragraphs (1) through (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:1..5", "@proposed": "true"}, {"#tail": " shall make publicly\n\t\t\t\tavailable, on the Internet Web site of the Food and Drug Administration,\n\t\t\t\tminutes of all negotiation meetings conducted under this subsection between the\n\t\t\t\tFood and Drug Administration and the regulated industry.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Before presenting the recommendations developed\n\t\t\t\tunder "}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "header": {"#tail": "\n                  ", "#text": "Public\n\t\t\t\tavailability"}, "#text": "\n                  ", "@id": "H246FC885DA654B329ADB64685190FBCC"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall summarize any substantive\n\t\t\t\tproposal made by any party to the negotiations as well as significant\n\t\t\t\tcontroversies or differences of opinion during the negotiations and their\n\t\t\t\tresolution.", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:742/ss:d/p:6/sp:A", "@proposed": "true"}, "#text": "The\n\t\t\t\tminutes described under "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "header": {"#tail": "\n                  ", "#text": "Content"}, "#text": "\n                  ", "@id": "H560A7610AE0244CCB4C19ABBA36C9653"}], "enum": {"#tail": "\n                ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Minutes of negotiation\n\t\t\t\tmeetings"}, "#text": "\n                ", "@id": "HEDF9BFDEC7564F94A5D82149C43EE982"}], "#text": "\n              ", "@id": "HA5EE00D3911E431A83D2630447A807AB"}], "#text": "\n            ", "@id": "H8DF60BA7FDDF4F5A98CEDC84C071F5E8"}, "@reported-display-style": "italic", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H0A02A82E9C974F99AF82F4B85CEA7F49"}, "#text": "\n        ", "@id": "HA2992BBB203C48F486BDBDF43BF9E1A0"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", as in effect on the day before the date\n\t\t\t of enactment of this title, shall continue to be in effect with respect to\n\t\t\t abbreviated applications for a generic new animal drug and supplemental\n\t\t\t abbreviated applications for a generic new animal drug (as defined in such part\n\t\t\t as of such day) that on or after October 1, 2008, but before October 1, 2013,\n\t\t\t were accepted by the ", "@entity-type": "act", "#text": "part 5 of subchapter C of chapter VII of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, {"#tail": " for filing with respect to\n\t\t\t assessing and collecting any fee required by such part for a fiscal year prior\n\t\t\t to fiscal year 2014.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "Notwithstanding the\n\t\t\t amendments made by this title, ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "204."}, "header": {"#tail": "\n        ", "#text": "Savings\n\t\t\t clause"}, "#text": "\n        ", "@id": "H83E3CC685FA74B32A47F803CED686D9C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", as amended by this\n\t\t\t title, shall be assessed for all abbreviated applications for a generic new\n\t\t\t animal drug and supplemental abbreviated applications for a generic new animal\n\t\t\t drug received on or after October 1, 2013, regardless of the date of enactment\n\t\t\t of this title.", "@entity-type": "act", "#text": "part 5 of subchapter C\n\t\t\t of chapter VII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VII/sch:C/pt:5"}, "#text": "The amendments made by\n\t\t\t this title shall take effect on October 1, 2013, or the date of enactment of\n\t\t\t this title, whichever is later, except that fees under ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n        ", "#text": "205."}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "HC2BA9599B1D34A349F78F644EFB91691"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "206."}, "header": {"#tail": "\n\t\t\t\t", "#text": "Sunset dates"}, "subsection": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease\n\t\t\t to be effective October 1, 2018.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 741 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:741", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201321", "@value": "usc/21/379j\u201321", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-21", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(a)"}, "header": {"#tail": "\n          ", "#text": "Authorization"}, "#text": "\n          ", "@id": "HCFF03F69BC6042D8A147B0395C50478B"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall cease to be effective January 31, 2019.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 742 of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:742", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 379j\u201322", "@value": "usc/21/379j\u201322", "@proposed": "true"}, "@parsable-cite": "usc/21/379j-22", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(b)"}, "header": {"#tail": "\n          ", "#text": "Reporting\n\t\t\t requirements"}, "#text": "\n          ", "@id": "H091DC25AA0C24B3097FDED366CB82EC4"}, {"#tail": "\n      ", "enum": {"#tail": "\n          ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Previous sunset\n\t\t\t provision"}, "paragraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is repealed.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 204 of the Animal Generic Drug User Fee Act of\n\t\t\t 2008", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, "@parsable-cite": "pl/110/316", "#text": "\n                  ", "@legal-doc": "public-law"}}}, "enum": {"#tail": "\n            ", "#text": "(1)"}, "header": {"#tail": "\n            ", "#text": "In\n\t\t\t general"}, "#text": "\n            ", "@id": "H220705ED3D394539AF25F58025E20772", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", by striking\n\t\t\t the item relating to ", "@entity-type": "act", "#text": "section 1", "@value": "Animal Generic Drug User Fee Act of 2008/s:1"}, {"#tail": ".", "@entity-type": "act", "#text": "section 204", "@value": "Animal Generic Drug User Fee Act of 2008/s:204"}], "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended in the table of contents in ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n\t\t\t (", "@entity-type": "public-law", "#text": "Public Law 110\u2013316", "@value": "public-law/110/316"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "122 Stat. 3509", "@value": "statute-at-large/122/3509"}], "@entity-type": "law-citation", "#text": "\n                "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(2)"}, "header": {"#tail": "\n            ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n            ", "@id": "HE22B1C4374324AD998965B9C304B511F", "@commented": "no"}], "#text": "\n          ", "@id": "HF884CD85657B44A59382E966BA6ACC78", "@commented": "no"}], "#text": "\n        ", "@id": "HDD72B01819D14FAB84BD9832B4014201"}], "enum": {"#tail": "\n      ", "#text": "II"}, "header": {"#tail": "\n\t\t\t", "#text": "Animal Generic Drug User\n\t\t\t Fee Amendments"}, "#text": "\n      ", "@id": "HEBFF3B7325FF4C888B5E64EFD09FC9B8"}], "#tail": "\n  ", "section": {"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Table of Contents"}, "toc": {"@committee-id": "HIF00", "@changed": "added", "#tail": "\n\t\t", "@lowest-level": "section", "@regeneration": "yes-regeneration", "toc-entry": [{"@idref": "HC1B45C56DC9E4AAA83E0BE7DCA371DFA", "#tail": "\n\t\t\t\t", "#text": "Sec.\u20021.\u2002Table of Contents.", "@level": "section"}, {"@idref": "H697D085308F348A1A36267CB66E55E5E", "#tail": "\n\t\t\t\t", "#text": "Title I\u2014Animal Drug User Fee\n\t\t\t\tAmendments", "@level": "title"}, {"@idref": "H534BB7E90262469980D59FD394E3EE1E", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002101.\u2002Short title; finding.", "@level": "section"}, {"@idref": "H5B3A475902894FABB16F5CC1DA256C8D", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002102.\u2002Definitions.", "@level": "section"}, {"@idref": "HDFCACF2D7F6048B094CEE81934FFC369", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002103.\u2002Authority to assess and use animal\n\t\t\t\tdrug fees.", "@level": "section"}, {"@idref": "H4B0D57F4F492484AB0026477B82E2463", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002104.\u2002Reauthorization; reporting\n\t\t\t\trequirements.", "@level": "section"}, {"@idref": "H0990EE7E1BA84E86963A121F3E3E804F", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002105.\u2002Savings clause.", "@level": "section"}, {"@idref": "H68DC208E871C4EE2BE4E11FC32B5AA99", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002106.\u2002Effective date.", "@level": "section"}, {"@idref": "H98B3FB34ADE143CB984081514FA7F305", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002107.\u2002Sunset dates.", "@level": "section"}, {"@idref": "HEBFF3B7325FF4C888B5E64EFD09FC9B8", "#tail": "\n\t\t\t\t", "#text": "Title II\u2014Animal Generic Drug User Fee\n\t\t\t\tAmendments", "@level": "title"}, {"@idref": "H264F43CF92334A8D98B1B02F32C4E877", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002201.\u2002Short title; finding.", "@level": "section"}, {"@idref": "H3E09AE53D7654C4EAE8B90062929F6ED", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002202.\u2002Authority to assess and use generic\n\t\t\t\tnew animal drug fees.", "@level": "section"}, {"@idref": "HA2992BBB203C48F486BDBDF43BF9E1A0", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002203.\u2002Reauthorization; reporting\n\t\t\t\trequirements.", "@level": "section"}, {"@idref": "H83E3CC685FA74B32A47F803CED686D9C", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002204.\u2002Savings clause.", "@level": "section"}, {"@idref": "HC2BA9599B1D34A349F78F644EFB91691", "#tail": "\n\t\t\t\t", "#text": "Sec.\u2002205.\u2002Effective date.", "@level": "section"}, {"@idref": "HDD72B01819D14FAB84BD9832B4014201", "#tail": "\n\t\t\t", "#text": "Sec.\u2002206.\u2002Sunset dates.", "@level": "section"}], "@quoted-block": "no-quoted-block", "@reported-display-style": "italic", "@lowest-bolded-level": "division-lowest-bolded", "@container-level": "legis-body-container", "#text": "\n\t\t\t\t"}, "#text": "\n      ", "@id": "HC1B45C56DC9E4AAA83E0BE7DCA371DFA"}, "@display-enacting-clause": "yes-display-enacting-clause", "@reported-display-style": "italic", "#text": "\n\t\t", "@id": "H79985F532EF149B9A4B4A3B35FD17F54"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-04-09"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1407 RH: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs."}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}